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ABSTRACT
In vitro expression of human zona pellucida protein 3
Chili-Wei Chen 
Old Dominion University 
and 
Eastern Virginia Medical School 
1995
Human zona pellucida protein 3 (hZP3) is the putative 
receptor on the zona pellucida of the mature oocyte that 
recognizes and binds sperm, and therefore plays a critical 
role in fertilization.
A full length cDNA of hZP3 (1278 bp) was amplified from 
the human ovary mRNA by reverse transcription-polymerase 
chain reaction (RT-PCR). The hZP3 cDNA was subcloned into 
PSK and pREP4 expression vectors. The cDNA of hZP3 was 
further characterized by restriction mapping, PCR, auto­
sequencing and Southern blot analysis by using an internal 
oligonucleotide probe, and found to be identical to the one 
reported by J. Dean. Using autosequencing, 289 bases were 
identified and more than 98% homology was found at the 3'- 
end with the reported sequence, whereas, 224 bases were 
identified and more than 91% homology was found at the 5'- 
end. In vitro translation was performed to ensure the 
capacity of the cloned cDNA for producing a full length,
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non-glycosylated hZP3 protein (47 kDa). Stable transfection 
of a human ovarian tumor cell line, PA-1, was produced by 
introduction of the hZP3/pREP4 expression vector construct 
using the calcium phosphate precipitation method. Approxi­
mately 200 single colonies of the stable-transfected cells 
were isolated by the cloning-ring method. Direct PCR, RT- 
PCR, and ELISA were used to identify and select clones; ten 
of the isolated clones were found to be positive.
Two of the ten selected clones (SKC-P3-12 and SKC-P3- 
19) were used for further studies. Culture medium was 
collected from transfected and non-transfected cells 
(negative control) , and the samples were purified by wheat 
germ agglutinin (WGA)-lectin chromatography and anti-WGA 
immunoaffinity chromatography; the final eluted fraction was 
concentrated by ultrafiltration with a limiting molecular 
weight cut off at 30 kDa. The secreted glycoproteins were 
identified by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) with silver staining, Western 
blot analysis using a specific anti-ZP3 antibody, and by a 
metabolic labelling study using 3H-galactose. Several bands 
including a band at 65 kDa, were observed in both non­
transfected and transfected medium by silver staining. 
Distinct bands were identified by Western blot analysis at 
65 kDa and 100 kDa for the recombinant product; solubilized 
human zonae pellucidae demonstrated a molecular mass of 
native hZP3 at approximately 65 kDa, and was at the same 
position identified for the recombinant product. In the
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metabolic study, several distinct bands including the band 
at 65 kDa, were identified as biosynthesized glycosylated 
recombinant proteins.
In the hemizona assay (a test for sperm-zona pellucida 
binding), a significant inhibition (>40%) of binding was 
observed in competition studies using a 1:4 dilution of the 
WGA-purified recombinant glycoprotein solution. This 
material did not affect sperm viability or motility, and 
induced a more than 50% increase in the acrosome reaction of 
sperm after overnight incubation.
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I. INTRODUCTION
A. Human fertilization
Fertilization is one of the most important and 
interesting subjects in the study of human reproduction 
because it concerns the first contact between the two 
gametes and the very beginning of human life. It occurs as a 
series of orchestrated and regulated events that culminate 
in the fusion of the sperm and oocyte to form a one-cell 
zygote, the obligatory precursor of all cells in the embryo.
Fertilization can be divided into the following 
sequence of events: (1) penetration of the cumulus mass by 
the sperm cells, (2) attachment and primary binding of sperm 
to the egg's zona pellucida, (3) induction of the acrosome 
reaction, (4) secondary binding and penetration of sperm 
through the zona pellucida, and (5) fusion of the ovum and 
spermatozoon and the activation of egg [1-8] .
Gametogenesis is the process of formation and 
development of gametes or germ cells. During spermato­
genesis, the chromosome number is reduced by half (haploid), 
and the shape of the cells is altered. A mature sperm cell 
must undergo two meiotic divisions and a process of 
differentiation which takes about sixty-four days to be
1
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completed. The mature sperm cell is a free-swimming, 
actively motile cell consisting of three regions, namely 
head, neck, and tail. The head contains the haploid nucleus, 
and the anterior two thirds of the nucleus is covered by a 
head cap known as acrosome which contains a large array of 
powerful hydrolyzing enzymes and structural proteins [7,9, 
10]. Among these enzymes, hyaluronidase and acrosin are the 
two acrosomal enzymes that have been most extensively 
studied and well characterized. It seems likely that a high 
degree of acrosomal organization may be required to assure 
the release of acrosomal components in a precise order as 
the spermatozoa penetrate through the egg's zona pellucida 
[7,9,11]. Interestingly, glycoprotein is a major component 
of the acrosomal matrix [11-13] and therefore is supposed to 
be important in many physiological functions of sperm during 
fertilization, including the conversion of proacrosin into 
enzymatically active acrosin [14-17]. Mitochondria are 
abundant in the proximal portion of the sperm tail, 
supplying the energy for the vigorous sperm motility [1,2,7, 
18] .
Spermatozoa that have matured in the epididymis are 
capable of moving actively, yet they still have to undergo 
the process known as capacitation to gain the capacity for 
fertilization after residing in the female tract for some 
period of time [19,20] . Even though the molecular basis is 
not fully understood, capacitation is believed to involve a
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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variety of metabolic/biochemical changes in preparation for 
fertilization [1,21].
Under in vitro conditions, and after about two hours 
of contact with capacitation medium, the spermatozoa begin 
to move much more actively than ever before. They swim in a 
characteristic movement seen as a very vigorous whiplashlike 
beating of the tail, often with the sperm head tracing an 
erratic figure-eight pattern (also known as nonprogressive 
or dancing movement) interspersed with brief episodes of 
linear movement. This is known as hyperactivity motility.
The strong thrusting power generated by the vigorous tail 
movements may facilitate spermatozoa in swimming through the 
viscous fluid of the oviduct [18,22-24] as well as the 
relatively thick zona pellucida [1,7,15,19,20,22,23,25,26].
Acrosome reaction as well as hyperactivity motility 
are the outcome of the capacitation process. The healthy 
sperm have to go through this modification step (capacita­
tion) , especially the modification of the composition of the 
cytoplasmic membrane, in order to make themselves suitable 
for a successful physiological response during acrosomal 
exocytosis and fertilization events [3,7, 8,21].
Many compounds have been found to demonstrate the 
ability for activating the acrosome reaction, for example, 
follicular fluid, hyaluronidase, calcium ionophores, and 
zona pellucida proteins. In fact, a large fraction of sperm 
lose their acrosomes before they reach the surface of zona
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pellucida during their penetration through the cumulus 
matrix. Although both of the acrosome-intact and acrosome - 
reacted sperm cells are able to attach to the zona pellucida 
in the mouse, the species best characterized so far, only 
the acrosome-intact ones are found to be capable of tight 
binding to the zona pellucida [7,17,27-36].
Zona pellucida protein 3 (ZP3) and zona pellucida 
protein 2 (ZP2) are, respectively, thought to be the first 
receptor and the second receptor for the specific 
recognition and binding between the zona pellucida and the 
sperm cells, but the detailed mechanism of their interaction 
is still unknown [4,6,37-39]. Generally speaking, the 
mechanism of acrosome reaction and even the individual 
physiological functions of the activators of the reaction, 
are still not clear.
B. Sperm-egg interaction and hZP3
In the mouse, sperm-egg interaction during 
fertilization consists of a sequence of events that take 
place in a compulsory order as follows (Fig 1) [2,5,7,8,
15,18,39]:
1) First of all, the sperm cells pass through the 
corona radiata and contact the oocyte. At this step, the 
attachment is random, loosely associated and not species- 
specific. Therefore the attached sperm can be usually washed 
away by simple agitation, and this is one of the most
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Fig 1. Sperm-egg interaction during fertilization: The mouse 
model. The picture is adapted and modified from reference 
(54). According to this model, a spermatozoon recognizes and 
binds with ZP3 (primary receptor in the zona) ,- this is 
followed by induction of the acrosome reaction by ZP3 in the 
zona-bound sperm cell; after this, a secondary sperm 
receptor is exposed and interacts with ZP2. This is followed 
by zona pellucida penetration.
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important steps of the hemizona assay (HZA) method which 
will be discussed in a later chapter.
2) Subsequently, some spermatozoa bind tightly and 
specifically with the oocyte via the interaction between 
sperm and oocyte receptors, i.e. ZP3 and its corresponding 
sperm receptor. This process is defined as the tight binding 
event. Unlike the previous attachment event, tight binding 
is thought to be irreversible, and it is generally agreed 
that tight binding is required to allow penetration of the 
specialized covering of the ovum, the zona pellucida [29] .
3) The acrosome reaction is the next event that 
follows the tight binding event. During fertilization, this 
organelle has to break to release its contained enzymes to 
enhance the penetration of the sperm into the zona 
pellucida. As we mentioned before, some sperm cells' 
acrosomes are broken during their penetration process 
through the cumulus matrix and follicular fluid, but only 
the acrosome-intact ones have the potential to penetrate the 
extremely thick extracellular matrix surrounding the ovum 
and fertilize the ovum. The acrosome reaction occurring 
between the intact sperm and the zona pellucida can be 
divided into two steps: (1) fusion of the outer acrosomal 
membrane and sperm plasma membrane, and (2) releasing of the 
associated enzymes and small membrane vesicles from the 
sperm head and inner acrosomal membrane. It is believed that 
the acrosome reaction is a signal transduced exocytosis
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process involving at least two of the protein kinase systems 
(protein kinase A and protein kinase C) [4,36,40,41], but 
the detailed mechanism is still to be clarified [16,30,31] .
4) The acrosome-reacted sperm cells are the only ones 
that have the chance to penetrate the zona pellucida and 
reach the perivitelline space. Normally only one of them is 
able to be the first and the unique one to fuse with the 
plasma membrane of the ovum, and then get into the ovum to 
form a zygote [29,32,42] .
5) Then the development of the zygote starts. 
Meanwhile, the electrical potential of the egg plasma 
membrane changes almost immediately after the spermatozoon 
reaches the ovum. The plasma membrane of the egg becomes 
"hardened" in seconds due to these effects, and therefore 
blocks additional sperm binding and penetration.
6) The zona pellucida is modified and becomes 
"hardened" by the releasing of enzymes from the cortical 
granules which are membrane bound, lysosome-like organelles, 
occupying a region of the egg cytoplasm just beneath the 
plasma membrane. The cortical granules which accumulated 
during oocyte growth as a product of the Golgi body, fuse 
with the egg plasma membrane and release their contents into 
the perivitelline space. This so called "zona reaction" 
happens in seconds after fertilization.
Among all these events, the event that influences the 
sperm binding to the zona pellucida is an initial, crucial
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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recognition step leading to fertilization. Recent investi­
gations into the molecular composition and genetics of the 
zona pellucida and sperm membrane receptors have provided 
much more detailed information about the molecular basis of 
this critical event during fertilization, especially in the 
murine species. It is well accepted that ZP3 has a major 
role on the specific, primary sperm binding to the zona, and 
has the potential to induce the sperm's acrosome reaction. 
This follows studies using both crude solubilized mixture of 
zonae pellucidae as well as intact eggs in the mouse model, 
which is the best characterized species so far in ZP3 
research [4,9,30,37,38,40,43].
C. Zona pellucida
Beginning at puberty, as the primary oocyte ensues 
development, the single layer of flattened, follicular 
epithelial cells surrounding the egg become cuboidal and 
then columnar, forming a primary follicle. The primary 
oocyte soon becomes surrounded by a covering of amorphous 
intercellular material known as the zona pellucida. In fact, 
the zona pellucida is a very thick and unique extracellular 
matrix surrounding the female gamete, constituted by zona 
pellucida fibers in a specific manner [28,44-46] . Compared 
to the oocyte itself, the thickness of the zona pellucida is 
more than half of the radius of the ovum inside depending on 
the species and the stages of the growing follicle [5,7] .
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The organization of the human zona pellucida is not 
yet clear, whereas the evidence obtained from immunohisto- 
chemistry and autoradiographic visualization demonstrate 
that at least two layers of organization exist in the human 
zona pellucida [28,44,45]. Each fiber is composed of several 
individual filaments in the mouse model and it may be 
similar in the human [44] .
It is believed that ZP3 and ZP2, which are two of the 
major components of the zona pellucida, bind together to 
form a dimer and the dimer acts as the building subunit of 
the zona filament (Fig 2). Another glycoprotein, ZP1 which 
is also abundant in the zona pellucida serves as linker 
between zona filaments and ZP3-ZP2 dimer subunits [7].
D. Zona pellucida proteins
The zona pellucida proteins (ZP1, ZP2, and ZP3) are 
distinguished from each other by differences of their 
characteristic migration positions on denaturing gel 
electrophoresis (SDS-PAGE). ZP3 is believed to be the 
primary sperm receptor, and ZP2 the secondary sperm 
receptor, whereas the function of the ZPl is structure- 
related [18,44,47].
Both the mouse and human ZP3 proteins are composed of 
424 amino acids, and are 67% identical in their amino acids 
composition with the greatest similarity in the center of 
the protein. The human ZP3 protein (12% acidic, 8% basic,
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Fig 2. Structure of the zona pellucida filaments: ZP3 (in 
black) and ZP2 (in white). In addition, ZP1 protein is 
another major component in the zona pellucida filament, but 
it is structure related, and is not shown in the figure. The 
arrow signs represent different oligosaccharides which are 
responsible for the recognition and binding with the sperm 
cell.
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7% aromatic, and 32% hydrophobic residues) has a calculated 
molecular mass of 47.032 Da (nonglycosvlated) [40] .
ZP3 has a very hydrophobic region consisting of 2 6 
amino acids near the carboxyl terminus which may play an 
important role in the intracellular trafficking of these 
secreted proteins or in their interactions in the extra­
cellular matrix [39,40].
In the mouse, the ZP3 is believed to have 3-6 complex- 
type N-linked carbohydrate side chains, and an undetermined 
number of 0-linked sugars [5,39]. The 0-linked oligo­
saccharides on ZP3 have been identified as the primary 
sperm-binding moiety [48] , and galactose and N-acetyl- 
glucosamine are two carbohydrates that have been implicated 
as essential for the sperm receptor activity of the zona in 
mice [49] . ZP3 and ZP2 share one common structure motif with 
a very hydrophobic region consisting of 23 and 26 amino 
acids respectively, near the carboxyl terminus. In the 
mouse, the ZP3 polypeptide chain has a 22 amino acids signal 
sequence for the glycosylation of the protein at its N- 
terminus [5,39,40,50-52].
Once the zona pellucida proteins are incorporated into 
the extracellular matrix, they are found to be very stable 
and have a long half-life, and it is estimated that the zona 
pellucida proteins in the natural conditions maintain their 
biological activities for days (>100 hr) [39].
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Compared to the mouse zona pellucida (mZP) , less 
information is available for the human zona pellucida (hZP). 
In the human, the acrosome-initiating activity of intact and 
solubilized human ZP has been reported [30,32,34,42] . 
However, these experiments are all performed by using very 
crude mixture samples with almost all of the zona pellucida 
components in it. Whether hZP3 alone or multi-components are
necessary for the induction of the acrosome reaction of
human sperm is still unclear. However, the intact and 
tertiary structure of ZP3 is suggested to be critical for 
the induction effect of the acrosome reaction [6,9] .
Similar to the mouse, the human zona pellucida is also
composed of three major glycoproteins: ZP1, ZP2, and ZP3. 
Besides, two isoforms of human ZP3 have been reported, named 
ZP3h and ZP3L, but whether they represent different post- 
transcriptional modifications of a single ZP3 gene product, 
the presence of an additional gene, or they simply just 
demonstrate the heterogeneous glycosylation products remain 
to be clarified [39,40,42,53].
The molecular weights of human zona pellucida proteins 
are species-related and demonstrate heterogeneity due to 
various degrees of glycosylation. According to J. Dean, the 
molecular mass of human zona pellucida proteins are:
ZP3. from 57 to 73 kDa.- ZP2, from 64 to 76 kDa; and ZP1, 
from 90 to 110 kDa [39] . The human ZP3 has a polypeptide 
backbone of 424 amino acids with complex type N-linked and
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O-linked oligosaccharide side chains [39]. The human 
polypeptide chain contains four potential N-linked 
glycosylation sites, and sixty-six potential O-linked 
glycosylation sites [40].
E. Developmental expression of hZP3 and the biosynthesis of 
glycoprotein
The synthesis of zona pellucida proteins is first 
detected when oocytes enter their two weeks growth phase 
before ovulation [39] . Investigation in the mouse model has 
concluded that the zona pellucida proteins are synthesized 
in only growing oocytes and secreted into the extracellular 
matrix [54-61] .
In a mouse experiment, various sizes of oocyte 
follicles in the ovary were isolated and the expression of 
ZP3 was monitored by the ratio of its mRNA among total RNA. 
At its peak in 30-35 fim diameter oocyte, zona pellucida 
synthesis represented 7-8% of total protein synthesis. Zona 
production declined in the fully grown oocyte and was absent 
or not detectable in ovulated eggs and the embryo [3 9] . In 
the ovulated eggs, the mRNAs of ZP2 and ZP3 are found to be 
200 nucleotides shorter than those found in the growing 
oocyte, implying the possibility of developmental regulation 
of the expression of the ZP gene between these two phases of 
the oocyte [56] . The mechanism for the regulation of the 
oocyte-specific and developmental expression of the ZP3 gene
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is still not clear, although it is believed the hormones and 
cytokines may play important roles on these functions [7].
Little is known on the human zona pellucida due to the 
difficulty in obtaining human oocytes and zona pellucida 
protein. Therefore, it was believed to be necessary to apply 
molecular biology techniques to supply enough hZP3 for 
investigation. Recent work reported an established Chinese 
Hamster Ovarian cell line (CH0-K1) transfected with a hZP3- 
reconstructed mini-gene which was capable of expressing a 
recombinant hZP3 glycoprotein. However, the reported 
molecular mass was at least 5 kDa lower than the native hZP3 
protein. The biological activity of the recombinant hZP3 
protein was only reported in acrosome reaction assays and 
sperm-egg fusion assays. The most important biological 
activity, that is the sperm ligand capacity, was not 
reported [62].
Since hZP3 is a glycoprotein, and the oligosaccharides 
have been proven to be critical for the biological functions 
of sperm-egg interaction [29,39,48-50,52,63-65], it is 
believed that the biological activity of the hZP3 is 
dependent on the secondary modification of the polypeptide 
backbone, that is the glycosylation. The glycosylation of a 
protein is thought to be species-dependent due to the 
different "glycosylation machinery" in various cell types, 
therefore, it is of highly interest to study the production 
of recombinant hZP3 glycoprotein in human ovarian cell
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lines. In addition, the "glycosylation machinery" is 
organized by the Golgi body and rough endoplasmic reticulum 
(RER), including their constituted glycosylation-related 
enzymes, and peptidyl-receptors. In addition, oligo­
saccharide -carriers, and the sugar transportation systems of 
the cell itself are also important for the biosynthesis of a 
glycoprotein.
It is believed that hZP3 has three complex type 
N-linked (asparagine-linked) oligosaccharide side chains and 
an unknown number of complex type O-linked oligosaccharides 
[39]. Typically, these two types of oligosaccharides in hZP3 
glycoprotein are both rich in galactose. The complex type 
asparagine-linked oligosaccharides contain a variable number 
of outer chains linked to a core of N-acetylglucosamine and 
mannose. The outer chains are consist mostly of galactose 
and sialic acid. In the complex type O-linked oligo­
saccharides, a similar core exists which is also rich in 
galactose residues (typically, >50%) [66-68].
One obvious difference between the biosynthetic 
pathways of these two types of oligosaccharides lies in the 
involvement of the oligosaccharide-pyrophosphate-dolichol 
(oligosaccharide-P-P-Dol) which is necessary for the 
biosynthesis of N-linked oligosaccharide but not O-linked 
oligosaccharides.
The pyrophosphate-dolichol (P-P-Dol) is important for 
the transportation of N-linked oligosaccharide, and
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 6
therefore the biosynthesis of N-linked oligosaccharide is 
dependent on the concentration of intracellular P-P-Dol. It 
is expected that P-P-Dol plays a crucial role for the 
regulation of glycosylation and biosynthesis of a glyco­
protein. The assembling, transferring, and processing of the 
oligosaccharide-P-P-Dol is finished in the RER and the 
product is localized on the inner membranes of the RER. 
Actually the glycosylation of all glycoproteins is started 
at the inner membrane of RER. And generally speaking, most 
of the modification, addition and deletion processes of the 
oligosaccharides of the glycoproteins is completed in the 
Golgi body.
F. hZP3 gene and cDNA
The human ZP3 gene is comprised of eight exons and the 
overall structure of the zona genes and their products is 
thought to be conserved among mammals. Using cross­
hybridization with mouse nucleic acid sequences as a 
criterion, the conservation of ZP3 genes of human is more 
related to mouse than that of pig and rabbit [39,40] .
Similar to mouse and hamster, the human ZP3 mRNA has 
short 5' and 3' untranslated regions which are very unusual 
and characteristic among all species found. The polypeptide 
of human ZP3 deduced from the open reading frame of its mRNA 
has a molecular mass of approximately 47 kDa and consists of 
424 amino acids [1,28,69-71].
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 7
The characterization of the cDNA encoding mouse ZP3 
has made the expression of recombinant ZP3 (rZP3) in tissue 
culture lines possible and represents a potential option for 
obtaining large amounts of murine ZP3. However, since 
glycosylation appears mandatory for ZP3-ligand function, it 
has been unclear whether rZP3 obtained from cells other than 
oocytes would possess the necessary post-translational 
modifications required for biological activity [37] .
Recently, a full length cDNA encoding mouse ZP3 was 
cloned into expression vectors [37]. Mouse L-929 cells and 
green monkey cells were transfected with the mouse ZP3- 
expression vector constructs, and the recombinant mouse ZP3 
protein (rmZP3) was purified by immunoaffinity chromato­
graphy from the culture medium and detected on Western blots 
using a mouse monoclonal antibody against an oligosaccharide 
side chain of hZP3. Although this rmZP3 differed slightly 
from native mZP3 in its molecular mass, it demonstrated 
biological activity in homologous murine sperm-zona 
pellucida competition assays and in triggering mouse 
acrosomal exocytosis in capacitated mouse sperm. Thus, 
according to these authors, rmZP3 isolated from both rodent 
and primate cells appears to contain those carbohydrate and 
protein structures necessary for ZP3's dual role in 
fertilization in the mouse.
Another approach has been tried by introducing a hZP3- 
minigene construct into the Chinese Hamster cell line (CHO-
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Kl) , but the recombinant hZP3 produced was at least 5 kDa 
lower in molecular mass even though the transfection process 
seemed to be successful. As discussed previously, the 
biological activity was not satisfactory [62] . These facts 
imply that the glycosylation process of hZP3 in the 
transfected host cell may be critical for the expression of 
biologically active hZP3.
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II. SPECIFIC AIMS
The specific aims of this study are: (1) To produce a full- 
length cDNA of hZP3 and to express human ZP3 in a human 
ovarian cell lines (PA-1) ; and (2) To characterize the 
biological activity of the recombinant product as sperm 
ligand and acrosome reaction inducer.
A. Significance
Many couples suffer from infertility, but in some of 
the cases the pathophysiological causes are still unclear. 
This mainly applies to male-factor infertility, where many 
cases are still considered "idiopathic", or, in other words, 
the cause is unknown. Even though in vitro fertilization 
(IVF) and other assisted reproductive techniques have been 
widely and successfully applied to these problems, little is 
known about their pathological origin, and the efficiency of 
the therapy is actually low and depends on an uncertain 
principle of "getting the gametes closer together". Because 
of our lack of complete understanding in the molecular 
details of fertilization, there is not an accurate and 
satisfactory tool or assay to assess all of these sperm 
dysfunctions. Recently, cellular and molecular advances in 
gamete biology have elucidated the structure and interaction
19
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of the binding receptors on the surfaces of both sperm and 
egg, principally in the mouse model. It is very interesting 
for us to study the binding receptors in human species by 
using molecular biology techniques.
Among several molecules involved in the event of 
fertilization, ZP3 protein is believed to be the first 
receptor in the zona pellucida that specifically recognizes 
and binds with the sperm. Therefore, ZP3 may play a very 
important role in fertilization, as determined during the 
pathophysiological study of some potential causes of male 
infertility and in the clinical diagnosis of fertility. In 
addition, ZP3 has been reported to be highly immunogenic 
[53,72-74] and therefore ZP3 may also be critical for the 
design of long-term immunocontraceptive methods.
The difficulty in obtaining enough human oocytes and 
preserving solubilized hZP3 protein has made further studies 
difficult due to the scant natural source of human ZP3. 
Therefore we sought to produce a stable transfected cell 
line to supply enough recombinant human ZP3 with biological 
activity for further studies by using molecular biology 
techniques.
The information provided by this study could have 
significant impact in many areas within the Reproductive 
Biology/Medicine field: (1) the physiology of human sperm-
zona pellucida interaction and pathophysiology of the 
clinical disorders affecting human fertilization may be
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critically reviewed and expanded (i.e., temporal relation­
ship between zona binding and penetration, acrosome reaction 
and motility patterns, isolation of the putative ZP3 
receptor from human sperm, etc.); (2) a solid or liquid 
phase assay may be developed using the artificial (re­
combinant) ZP3 thus giving access to a much simpler and 
universally applicable clinical diagnostic method to assess 
human sperm-zona pellucida interaction; and (3) the 
generation of a "naturally" glycosylated recombinant ZP3 may 
be exploited for engineering a contraceptive vaccine against 
the human zona pellucida and therefore advance fertility 
regulation research.
B. Experimental design
Our initial approach consisted of the isolation of 
mRNA from the human ovary, followed by the use of RT-PCR for 
generation of a full length cDNA for human ZP3. The cDNA was 
then purified by the geneclean glass-milk method and was 
respectively subcloned into PSK and pREP4 expression 
vectors. Autosequencing, Southern blot analysis, restriction 
mapping, PCR and in vitro translation were performed to 
identify the cDNA of hZP3.
The hZP3/pREP4 DNA construct was stably transfected 
into human ovarian PA-1 cell line by the calcium phosphate 
precipitation method. Single colonies were isolated by the 
cloning-ring technique [75]. PCR was performed to confirm
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the integration of the inserted cDNA into the genomic DNA of 
the host cell. Because that the mRNA of zona pellucida 
proteins are expressed in the oocytes at their two-weeks 
growth phase before ovulation, and there is little or no 
mRNA of ZP3 found in ovulated oocytes in the study of the 
mouse model [39,57], there will be no mRNA expected in the 
non-transfected PA-1 cells. RT-PCR was performed to identify 
the expression of the inserted cDNA in transfected cells. 
Identification of the production of hZP3 protein was 
performed by ELISA and Western blot analysis. A metabolic 
labelling study by substitution of 3H-galactose in the 
culture medium was performed to identify the glycosylated 
product of hZP3 expression. Solubilized human zonae 
pellucidae were used as positive controls. Lectin-affinity 
chromatography, immunoaffinity chromatography and ultra­
filtration were used for protein isolation and purification.
The biological activity of the recombinant ZP3 was 
assessed in two ways: (1) The capacity of the recombinant 
protein to compete (competitive inhibition) with the natural 
zona pellucida for sperm binding was examined by the 
hemizona assay. Dose-response studies were performed to 
determine the efficiency of the recombinant ZP3 as a sperm 
ligand, and sperm motility was also monitored to further 
characterize the biological activity. (2) The capacity of 
the recombinant protein to induce a "physiologic" acrosome 
reaction was assessed by using lectin staining (Pisum
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sativum agglutinin) staining combined with immunofluorescent 
techniques. Consequently, the criteria used for the identi­
fication of the secreted recombinant protein were immuno- 
genicity, molecular mass, and biological activity.
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III. MATERIALS AND METHODS
A. Materials
1. Oligonucleotide primers:
Oligonucleotide primers (CH-1, CH-2, and SI primers) 
were designed for this study as follows: CH-1 primer 
(5' ACCATGGAGCTGAGCTATAGG 3') and CH-2 primer 
(5'TTATTCGGAAGCAGACACAGG 3') were purchased from Oligos,
Etc. (Wilsonville, OR). SI primer (5' GTCAGCCGGGCCTTCCACTGG 
3') was synthesized at the Microbiology Department, EVMS.
(Dr. Stenberg)
2. Cells, vectors and culture supplies:
A human ovarian tumor cell line, PA-1, was purchased 
from American Type Culture Collection (ATCC CRL 1572, 
Rockville, MD). XLl-Blue Ecoli cells were from Strategene 
(La Jolla, CA). pBluescript SK (+) vector (PSK) was 
purchased from Stratagene. A mammalian cell expression 
vector, pREP4, was purchased from Invitrogen (San Diego,
CA). Trypsin-EDTA solution and minimum essential medium 
eagle (MEM) were purchased from Sigma (St. Louis, Mo). Fetal 
bovine serum (FBS) was from Hyclone (Logan, Utah), Ham's F- 
10 was from Gibco Lab (Grand Island, NY).
24
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 5
3. DNA markers:
DNA molecular weight marker III was purchased from 
Boehringer Mannhein (Indianapolis, IN), and 123 DNA ladder 
was from Gibco BRL technologies (Grand Island, NY).
4. Radioactive materials:
[7"32P] -Deoxyadenosine 5'-triphosphate for radioactive 
labelling of oligonucleotide probe and 35S-methinine 
(translation grade) for in vitro translation were purchased 
from Du-Pont NEN (Boston, MA) . 13C-protein rainbow marker 
(14.3-200 kDa) for fluorography was purchased from Amersham 
(Arlington Heights, IL).
5. Enzymes and other chemicals:
Restriction enzymes used in recombinant DNA procedures 
were purchased from New England BioLabs (Beverly, MA), 
Promega (Madison, WI) and Boehringer Mannheim.
Most of the chemical materials purchased from Sigma 
Chem. Co. (St. Louis, MO) except the following materials:
TNT T3 Couple reticulocyte lysate (for in vitro 
translation), polytract mRNA isolation kit, Magic Maxiprep 
kit (for plasmid DNA isolation), T4 polynucleotide kinase, 
alkaline phosphatase (Calf intestine), Tag polymerase (for 
"direct PCR" and "RT-PCR diagnosis", see Methods), lysozyme, 
RNasin and dNTPs were purchased from Promega. Taq polymerase 
(for production of full length cDNA of hZP3), Proteinase K,
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IPTG (isopropyl-beta-thiogalactopyranoside) and X-Gal (5- 
bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) were 
purchased from Stratagene. M-MLV reverse transcriptase, DTT 
and oligo(dT) 12.lg were from Gibco BRL. (FITC)-labeled Pisum 
Sativum agglutinin (PSA), Vectastain Alkaline Phosphatase 
ABC kit, BCIP/NBT kit, Wheat germ agglutinin (WGA) lectin 
and anti-WGA antibody were from Vector (Burlingame, CA) . The 
non-radioactive protein rainbow marker (14.3-200 kDa) was 
purchased from Amersham, Geneclean glassmilk (for DNA 
isolation) was purchased from Biol 101 (La Jolla, CA) , BCA 
protein assay kit was from Pierce, sheared salmon sperm DNA 
was from 5 prime -> 3 prime Inc. (Boulder, CO), TMB (for 
ELISA) was purchased from Pierce (Rockford, IL), peroxidase- 
Goat-anti-rabbit-IgG (H+L) was from Zymed (San Francisco,
CA) and fluorographic amplification reagent was purchased 
from Amersham.
6. Non-chemical materials:
Most of the non-chemical supplies were purchased from 
Fisher (Pittsburgh, PA), or Costar Corning (Cambridge, MA) 
except the following materials.
PCR reaction tube was purchased from Perkin Elmer 
(Norwalk, CT), Whatman 3 MM paper was from Schleicher & 
Schuell (Keen, NH), dialysis tubing (3500 Da MW cut off) was 
from Spectra (Houston, TX), X-ray film (Fuji RX) was from 
Fisher, nitrocellulose membrane (0.45 /xm) was from Costar
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and Centricon and Centriprep (with 30 kDa cut-off) were 
purchased from Amicon (Beverly, MA).
B . Methods
1. Cell culture
PA-1 (ATCC CRL) and the transfected cells were 
cultured with MEM containing 10% FBS [77,78]. Typically, 
confluent cells were split at 1:6 dilution in MEM containing 
10% FBS. The stable transfected cells were maintained in MEM 
with 150 /ig/ml of hygromycin (antibiotic) for at least three 
weeks to establish the stable transfection cells, and then 
the culture was continued in regular medium for further 
application [76]. FBS with 9% Dimethylsulfoxide (DMSO) was 
used as cryogenic medium for the storage of cells. The cells 
were spun down, washed by PBS buffer, resuspended in the 
cryogenic medium, and then frozen in liquid nitrogen 
following standard procedures.
2. Medium collection from the culture cells
For ELISA, the culture medium was collected when the 
cells reached 70% confluence to get a detectable amount of 
the recombinant glycoprotein secreted. The collected medium 
was centrifuged promptly to separate the supernatant, and 
protease inhibitors (1.0 mM PMSF, 0.7 mg/ml Pepstatin A, 0.5 
mg/ml Leupeptin, and 1.0 mM EDTA) were added. The samples
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were stored at -80 °C until used [79] .
For the isolation of the recombinant glycoprotein by 
the chromatography method (described later), culture medium 
was collected in short periods of culture by using the 
following procedure: Cells were adjusted to 15% confluence 
in medium (MEM) containing 10% FBS, cultured for 4 hr to 
allow cells to attach to the plate, washed once with PBS to 
remove the suspended cell bodies. Then culture medium was 
changed by 5.0 ml of fresh MEM with 10% FBS. Culture medium 
was collected every 12 hr until the cells reached 70% 
confluence. The collected medium was treated as above 
description (protease inhibitors added and centrifuged 
promptly) and stored at -20°C until used.
3. Isolation of RNA
Glassware used for the RNA isolation was all baked at 
200°C overnight. Plastic centrifuge tubes were thoroughly 
rinsed before usage with washing solution (0.1 N NaOH, 1.0 
mM EDTA), and then rinsed with RNase-free water. Other 
plasticware was soaked in 0.05% diethyl pyrocarbonate (DEPC) 
overnight to remove the organic impurity and then autoclaved 
for 30 min to degraded residual DEPC. All solutions were 
treated with 0.05% diethyl pyrocarbonate (DEPC) overnight at 
room temperature and then autoclaved for 30 min to remove 
any trace of DEPC.
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Isolation of total RNA from the human ovary
Total RNA was isolated by modifying Chirwin's 
guanidine thiocyanate method [80]. "Denaturing solution" was 
prepared by adding 132.0 ml of CSB buffer (0.042 M sodium 
citrate, 0.028 M N-lauroylsarcosine, 0.0014% mercapto- 
ethanol, pH 7.0) to 100.0 g of guanidine thiocyanate. An 
aliquot of 12.0 ml of "denaturing solution" was dispensed 
into a sterile 50 ml centrifuge tube and chilled on ice for 
5 min. Approximate 1.0 g of human ovary was chopped into 
small pieces by sterile surgical knife, transferred into the 
denaturing solution, and homogenized by a polytron. After 
1.2 ml of sodium acetate solution (2.0 M, pH 4.0) was added 
to the lysed cell solution, the RNA was extracted with 12.0 
ml of phenol:chloroform:isoamyl alcohol (25:24:1). The RNA 
was precipitated at -20°C overnight by adding 1 volume of 
isopropanol. The RNA was pelleted by centrifugation at
10,000 x g for 15 min at 4°C, washed with 12.0 ml of 75% 
ethanol, dried in a vacuum desiccator for 20 min, and then 
dissolved in RNase-free water for storage at -20°C. Finally, 
the concentration of RNA was determined by measuring the 
absorbance at 260 nm [81].
Isolation of mRNA
The mRNA was further purified by the method of 
polytract mRNA isolation system following manufacturer's 
description (Promega). A biotinylated oligo(dT) primer was
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used in the system to hybridize to the 3'poly(A) region 
present in eukaryotic mRNA species. The mRNA-biotinylated 
oligo(dT) hybrids were captured by paramagnetic particles 
which were pre-coupled with streptavidin at high stringency, 
washed thoroughly and then isolated by using a magnetic 
separation stand. The mRNA was eluted from the solid phase 
with RNase-free water.
One milligram of total RNA isolated as described above 
was brought to a final volume of 500 /liI in RNase-free water. 
For the purpose of annealing of biotinylated-oligo-(dT)ms 
primer with the mRNA, the total RNA solution (500 fil) was 
incubated at room temperature for 10 min by adding 3.0 n± of 
the biotinylated-oligo (dT) 12.18 primer and 13.0 /xl of 20 x SSC 
(3.0 M NaCl, 0.3 M sodium citrate, pH 7.0).
Streptavidin-coupled magnetic sphere particles (SA- 
PMPs) were prepared by gently flicking the bottom of the 
tube until completely dispersed, and captured by placing the 
tube in the magnetic stand. The SA-PMPs were collected at 
the side of the tube, washed three times with 0.5 x SSC (0.3 
ml each) and then resuspended in 0.1 ml of 0.5 x SSC.
In order to isolate the mRNA, the entire content of 
the annealing reaction above was added into the tube which 
contained the washed SA-PMPs, and the reaction was incubated 
at room temperature for 10 min. Then the mRNA-oligo(dT) 
hybrids were captured by SA-PMPs, washed four times with 0.1 
x SSC (0.3 ml per wash) , and then eluted from SA-PMPs by
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two fractions of 0.1 ml of RNase-free water. The eluted mRNA 
solution was centrifuged again at 10,000 x g at 4°C in order 
to remove the magnetic particles.
Isolation of cytoplasmic RNA (sucrose gradient method)
For the purpose of clonal selection of the stable 
transfected cells by RT-PCR, the total cytoplasmic RNA was 
isolated by sucrose gradient method as follows: A plate of 
70% confluent cells was washed with sterile PBS, and then 
the cells were scrapped out from the petri dish by a rubber 
policeman with 500 /xl of lysis buffer (1.5 mM MgCl2, 0.5% 
NP-40, 0.25% Sodium deoxycholate, 0.3 M sucrose, 10.0 mM 
Tris, pH 7.4) on ice. The cell lysate was carefully laid 
onto a 350 /xl of Cushion buffer (1.5 mM MgCl2, 10.0 mM Tris, 
0.4 M sucrose, pH 7.4) and spun at 5000 x g for 10 min at 
4°C. A 500 /x1 fraction of the upper aqueous solution was 
transferred to a fresh tube. Then 58.0 /xl of 10 x STE buffer 
(0.1 N NaCl, 10.0 mM Tris, 1.0 mM EDTA, pH 8.0) , 12.0 /xl of
10.0 mg/ml of proteinase K, and 17.0 /xl of 5.0 M NaCl were 
added. The mixture was incubated at 45°C for 45 min, 
extracted with equal volume of phenol:chloroform (1:1). The 
RNA was precipitated overnight at -20°C with equal volume of 
isopropanol, spun down and washed once with 1.0 ml of 70% 
ethanol. The RNA pellet was dried and dissolved in RNase- 
free water. The quality of RNA was assessed spectrophoto- 
metrically (A^/A^) and by agarose gel electrophoresis [81].
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
3 2
4. RT-PCR
The purified mRNA was reversed transcribed to cDNA, 
and then the hZP3 cDNA was specifically amplified by PCR.
The RT reaction was performed as follows: One microgram of 
mRNA, 20.0 units of RNasin, 100.0 pmol oligo(dT) 12.18, 1.0 mM 
of each dNTPs (dATP, dTTP, dCTP, and dGTP), 10.0 mM DTT and 
100 U of M-MLV reverse-transcriptase were added in 5 x first 
strand buffer (250 mM Tris-HCl (pH 8.3), 375 mM KC1, 15.0 mM 
MgCl2) , and the final volume was added up to 20.0 /xl by 
DEPC-treated water. The reaction was performed at 37°C for 
30 min, then at 42°C for 15 min, stopped by incubation at 
95°C for 5 min and chilled on ice at once [83] .
The RT reaction above was directly applied to a PCR. 
The PCR was accomplished by using a pair of 21 base-pairs 
(bp) oligonucleotide primers (CH-1 primer and CH-2 primer, 
see Materials) designed based on the published sequence of 
the cDNA of human ZP3 [40]. The synthesized first-strand 
cDNA (20.0 /xl) described above was denatured at 100°C for 3 
min and then amplified by PCR with 2.5 U Taq polymerase by 
adding 15 pmole of each CH-1 and CH-2 primers and 10.0 /xl of 
10 x PCR reaction buffer (100 mM Tris-HCl (pH 8.8), 500 mM 
KC1, 15.0 mM MgCl2, 0.1% (w/v) gelatin) in a final reaction 
volme of 100 /xl. The thermocycler was programmed as follows: 
94°C denaturing for 1 min, 55°C annealing for 1 min, and 72°C 
extension for 30 sec with a 2 sec extension per cycle, for a 
total of 35 cycles of amplification, followed by final
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5. Subcloning of the cDNA of hZP3
The RT-PCR product was blunt-end ligated with EcoRI 
linkers, and then inserted into the PSK vector. In order to 
create blunt-ends, the RT-PCR product was subjected to a 
fill-in reaction at room temperature for 30 min by adding
2.5 mM of each dNTPs and 2.5 U the Klenow (large fragment of 
DNA polymerase I). For blunt-end ligation, EcoRI linkers 
were phosphorylated by T4 polynucleotide kinase. The fill-in 
reaction was heat-inactivated at 75°C for 20 min and then 
combined with the linker reaction prepared above. This was 
followed by addition of T4 DNA ligase and 10 x ligase buffer 
(500 mM Tris-HCl (pH 7.8), 100 mM MgCl2, 100 mM DTT, 10.0 mM 
ATP and 500 /ig/ml BSA) , and incubated for 5 hr at 15°C for 
the purpose of blunt-end ligation. The reaction was again 
heat-inactivated at 75°C for 20 min, and EcoRI was then 
added to produce EcoRI sticky ends on the blunt-end ligated 
DNA in order to be inserted into the EcoRI site of the 
vector (PSK) [81,82].
Meanwhile, the PSK vector was digested by EcoRI, 
purified by phenol extraction. To prevent recirculation of 
the sticky-ends vector, the DNA solution was 5'-end 
dephosphorylated with alkaline phosphatase (CIAP, Promega).
Fine-ground glassmilk (Geneclean protocol, Biol 101) 
was utilized to purify the DNAs prepared above. The purified
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hZP3 DNA prepared above, was ligated with the prepared PSK 
vector at 4-16°C for 18 hr. The DNA construct (hZP3/PSK) was 
transformed into XLl-Blue competent cells, using the Mandel 
and Higa method [71] and plated onto X-Gal ampicillin- 
agarose. The white clones were selected and grown in LB 
medium with 75 /xg/ml ampicillin at 37°C.
The DNA plasmid (hZP3/PSK) was isolated from the 
selected clones by the alkaline-detergent method (mini-prep 
method) [81] and identified by restriction mapping (using 
BstXI, MvnI, and Seal restriction enzymes) [40], Southern 
blot analysis (using a probe designed to identify an 
internal sequence of the cDNA), and PCR (using the same 5' 
terminal primer used in previous RT-PCR and the internal 
probe used in Southern blot analysis). In addition, in vitro 
translation (TNT T3 coupled reticulocyte lysate system, 
Promega) using radioactive methionine was carried out to 
ensure that a full length protein (non-glycosylated ZP3) is 
synthesized by this cDNA of hZP3 as determined by SDS-PAGE 
and autoradiography.
In order to express the cDNA of hZP3 in mammalian 
cells (human ovarian tumor cell), the cloned cDNA was 
subcloned into a mammalian cell expression vector (pREP4). 
The plasmid DNA (hZP3/PSK) isolated from the selected clones 
was digested with BamHI and Xhol restriction enzymes to 
produce sticky ends and then ligated with the episomal 
expression vector pREP4 (containing the Rous sarcoma virus
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promotor and hygromycin-resistant gene) with T4 DNA ligase 
at 4-16°C for 18 hr. Restriction mapping, Southern blot 
analysis and PCR were again performed to select the correct 
clones. Approximately, 300 clones were analyzed. Spin column 
(Maxiprep, Promega) was used to produce high quality and 
large amounts of supercoiled DNA construct for the further 
application. Further purification of the cDNA construct was 
achieved by alcohol precipitation with the addition of 0.3 M 
sodium acetate at -80°C for 4 hr.
6. 5'-end radioactive labelling of oligonucleotide probe
The reaction for the radioactive labelling of the 
oligonucleotide probe SI (see Materials) for Southern blot 
analysis was performed at 37°C for 10 min by adding 200 ng 
of the internal probe (SI) , 70 /xCi of [y-32P]ATP and 10 U of 
T4 polynucleotide kinase in 1 x forward exchange buffer (50 
mM Tris-HCl, 10.0 mM MgCl,, 0.1 mM spermidineand and 5.0 mM 
DTT, pH 7.5) with a final volume of 10.0 /xl. The reaction 
was stopped by adding 5.0 /*1 of 0.1 M EDTA. Right before 
use, the radioactively labelled SI probe solution was boiled 
for 10 min and then chilled on ice.
7. Southern blot analysis
Southern blot analysis was performed to identify the 
DNA constructs of the cDNA of hZP3 by using an internal 
probe SI [81]. DNAs were run on an agarose gel, then the gel
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was soaked in denaturing solution (1.5 M NaCl, and 0.5 M 
NaOH) for 45 min, and then in neutralization solution (1.5 M 
NaCl, 1.0 M Tris, pH 7.4) for 30 min. Blot transfer of DNA 
fragments to nitrocellulose membrane was performed by 
capillary action (simple diffusion method) in 10 x SSC 
buffer (1.5 M NaCl, 0.15 M sodium citrate, pH 7.0) for 16 hr 
[81]. The blot membrane was air-dried on a 3 MM paper for 30 
min, UV cross-linked at 0.12 joules per cm2 of membrane for 
1 min, and then prehybridized in a sealable bag with pre­
hybridization solution (25.0 mM KÎ PO,,, 5 x Denhardt's 
solution, 50 ^g/ml salmon sperm DNA, and 50% formamide in 5 
x SSC buffer) at 42°C for 3 hr by gentle shaking [81] .
The prehybridization solution was removed from the 
sealable bag and the blot membrane was transferred to a new 
bag containing the prepared oligonucleotide probe in hybri­
dization solution (the same as prehybridization solution but 
without the Denhardt's solution). The bag was placed in 
water bath at 42°C with gentle shaking for 10 hr. The 
membrane was removed and washed in 1 x SSC with 0.1% SDS 
twice for 15 min each at room temperature, and then in 0.25 
x SSC with 0.1% SDS twice for 15 min each at 42°C. The 
membrane was then air-dried on a piece of 3 MM paper, 
wrapped in saran wrap and put in a Kodak X-ray holder with 
Kodak XAR-5 X-ray film and intensifying screen for an 
appropriate duration of time at -70°C.
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8. In vitro transcription/translation
TNT Couple Reticulocyte Lysate system was used to test 
the capacity of the cloned hZP3 cDNA to produce a full 
length nonglycosylated protein following manufacturer's 
instruction. DNA template (2.0 /xg) was added into 25.0 /x 1 of 
TNT rabbit reticulocyte lysate. Then 2.0 (il of TNT reaction 
buffer (Promega) , 1.0 /x 1 of T3 RNA polymerase, 1.0 /x 1 of 
amino acid mixture without methionine, 4.0 jxl of 35S- 
methionine (1000 Ci/mmol at 10 mCi/ml) , and 40 U of RNasin 
(RNase inhibitor) were added into the DNA solution above, 
and the final volume was adjusted to 50.0 /xl by RNase-free 
water. The reaction was performed at 30°C for 2 hr.
Luciferase DNA was used as a positive control, and the 
plasmid with opposite orientation insertion of hZP3 cDNA 
into PSK vector was used as a negative control. In order to 
analyze the result of translation, a discontinuous SDS-PAGE 
was run (with 10% separating gel and 4% stacking gel) , gel 
was dried by gel-drier, and autoradiography was performed as 
described before.
9. DNA purification by CsCl ultracentrifugation
For the purpose of cell transfection, DNA construct 
(hZP3/pREP4) was further purified by ultracentrifugation in 
CsCl as follows: One liter of cells incubated overnight was 
pelleted at 5000 x g for 5 min and then was resuspended in
30.0 ml of alkaline lysis solution I (50.0 mM of glucose,
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10.0 mM EDTA and 25.0 mM Tris, pH 8.0) by shaking and 
vortexing. A 30.0 ml of lysis solution buffer II (0.2 M NaCl 
and 1% of SDS) was added, and the mixture was incubated on 
ice for exactly 5 min. Then 22.5 ml of 5.0 M potassium 
acetate (pH 5.5) was added, and the lysate solution was 
incubated on ice for exactly 5 min. Centrifugation was 
performed at 10,000 x g for 2 0 min at 4°C and the super­
natant containing DNA was carefully transferred to another 
tube. DNA was precipitated at room temperature for 20 min by 
adding 1 volume of isopropanol, spun down, air-dried, and 
then dissolved in 15.0 ml of TE buffer (1.0 mM EDTA, 10.0 mM 
Tris.Cl, pH 7.4).
Purification was achieved by sequential extraction one 
time with 1 volume of phenol, once with one volume of 
phenol: chloroform: isoamyl alcohol (25:24:1), and one time 
with one volume of chloroform: isoamyl alcohol (24:1). DNA 
was precipitated at -20°C overnight by adding 2.5 volumes of 
100% ethanol and 0.3 M sodium acetate (pH 5.2), spun down, 
air-dried, and dissolved in TE buffer again to a final 
volume of 17.0 ml. Then 1.9 ml of 5% lauroylsarcosine 
solution and 19.6 g CsCl were added and mixed well until 
CsCl dissolved completely. After 1.2 ml of 10.0 mg/ml of 
ethidium bromide was added, the solution was separated to 
two "heat sealable" centrifuge tubes. Balance was corrected 
up to 0.1 g. The tubes were capped by heat, and then centri­
fugation was performed at 55,000 rpm (26,000 x g) with a
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VTi65 rotor for 16 hr. The supercoiled DNA (the lower band) 
was collected through the side of the tube by syringe (with 
18 gauge needle) under UV lamp, and was extracted with 
water-saturated n-butanol to remove the ethidium bromide 
until clear by checking under UV light.
The solution was dialyzed overnight with 2 1 TE buffer 
to remove CsCl, and then DNA was precipitated at -20°C 
overnight by adding 1/10 volume 3.0 M sodium acetate (pH
5.2) and 2.5 volume 100% ethanol. The DNA was spun down, 
washed with 70% ethanol, air-dried, and then dissolved in 
0.5 ml of TE buffer (pH 7.0). The concentration and quality 
was measured with A^ and spectrophotometrically [81] .
10. Stable transfection
PA-1 cell was stably transfected with the hZP3/pREP4 
DNA construct by using calcium phosphate-mediated trans­
fection method [81,82] . A 50 /xg/ml of DNA solution was 
prepared by adding 62 /*1 of CaCl2 and sterile water to a 
final volume of 0.5 ml. The DNA solution was added dropwise 
into 0.5 ml of sterile 2 x HBS (280 mM NaCl, 10.0 mM KC1,
1.5 mM Na,HP04.2H,0, 12.0 mM dextrose, and 50.0 mM HEPES, pH 
7.05) under a stream of air, and then incubated at room 
temperature for 20 min to precipitate DNA. Right before use, 
the DNA precipitate was dispersed by vortex gently (speed 4 
with a Vortex-Genie (Scientific Industries Inc, NY)) for 10 
sec, and the medium was removed from the cells. The calcium
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phosphate-precipitated DNA suspension was transferred 
carefully onto the cell monolayer and incubated at room 
temperature for 15 min.
Culture medium (MEM with 10% FBS) was then laid gently 
onto the cells. The cells were cultured for 18 hr to allow 
endocytosis happen, washed twice by PBS, and cultured for 
another 24 hr in regular medium.
Selection medium (regular medium with 150 /xg/ml of 
hygromycin) was then used for three weeks to established the 
stably transfected cells [76,81,84,85], and the selection 
medium was changed every 2-3 days.
Cloning ring with 3 mm internal diameter was used to 
isolate the viable single colonies [75], and trypsin-EDTA 
was used to release cells. Approximately, 150 single 
colonies were isolated.
The integration of hZP3/pREP4 DNA into the host 
genomic DNA was identified by PCR, the expression of the 
cDNA of human ZP3 in the transfected cells was assessed by 
RT-PCR and the secretion of recombinant protein was assessed 
by ELISA (described later).
When the selected single colonies of transfected cells 
reached about 70% confluence in six-wells clusters, the 
cells were harvested, resuspended in cryogenic medium (9% 
DMSO/FBS), and stored in liquid nitrogen by following 
standard protocol.
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11. RT-PCR for the clonal selection of stable-transfected 
cells
RT-PCR was performed for the identification of hZP3 
cDNA expression in the transfected cells. The cytoplasmic 
total RNA was isolated by the method described before, 
dissolved in RNase-free water, and stored at -20°C if not 
used immediately [83].
In order to select the stably transfected clones from 
a large number of candidate clones, total RNA (10 /xg) was 
used instead of mRNA in this RT-PCR. The RT reaction was 
performed as described before except that 1.5 mM of each 
dNTPs (dATP, dTTP, dCTP and dGTP) and 0 .5 /xg BSA were used 
to optimize the reaction. In addition, reaction was 
performed at 37°C for 1.5 hr, stopped by adding 30 fxl of 
sterile water, incubated at 95°C for 5 min and then cooled 
on ice immediately.
The RT reaction was followed directly by PCR reaction. 
Only 7.5 ^1 of the RT final solution (prepared above) was 
used to perform a PCR, the remaining material was stored at 
-20°C. The sample used was equivalent to the RT product of
1.5 tig of total RNA.
The PCR was optimized by the following conditions:
Each CH-1 and SI primer (see Materials) was added in the
amount of 0.15 ixM into 7.5 /x 1 of the RT solution. Then 2.0
mM MgCl,, 2 U Taq polymerase, and 0.1 mM of each dNTPs were
added in 5.0 fxl PCR reaction buffer and the final volume was
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brought to 50.0 pi with sterile water. The thermocycler was 
programmed as follows: 94°C denaturing for 45 sec, 55°C 
annealing for 1 min, and then 72°C primer extension for 1 
min, for a total 35 cycles of amplification, followed by a 
final extension at 72°C for 5 min.
12. Isolation of genomic DNA
The genomic DNA was isolated by Higuchi's method [86]. 
The cells were lysed in a alkaline buffer containing non­
ionic detergents and Proteinase K. In this method, the RNA 
was destroyed by alkaline hydrolysis, and the DNA remained 
intact and was used directly in PCR.
A "PCR buffer" (50.0 mM KC1, 0.1 mg/ml gelatin, 0.45% 
NP -40, 0.45% Tween 20, 2.5 mM MgCl2 and 10.0 mM Tris, pH
8.3) was prepared, autoclaved and stored frozen. When ready 
to use, the buffer was thawed, and 0.6 pi of 10.0 mg/ml 
Proteinase K was added per 100 p 1 of the solution.
A 40 mm dish of cells were washed with PBS, scrapped 
free by rubber policeman, and resuspended in 150 pi of the 
prepared buffer (to make a solution of about 6 x 106 cells 
per ml). The cell suspension was incubated at 55°C for 1 hr 
to lyse the cells, release chromosomal DNA from histone, and
hydrolyze the RNA. Then the proteinase K was inactivated at
95°C for 10 min. The lysate was either stored frozen at -20°C 
or used directly as sample for PCR. Typically, 25 pi of the 
lysate thus prepared was about 1 pg of genomic DNA according
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to Higuchi's estimation [86].
13. PCR for the clonal selection of the stable-transfected 
cells
A PCR was performed to verify genomic integration of 
the hZP3 cDNA construct in transfected cells.
The conditions for the PCR were optimized as follows: 
Two microliters of the lysate mentioned above (which was 
about 80 ng of the genomic DNA), 1.0 mM of MgCl2, 0.4 mM of 
each dNTPs, 2.5 U of Taq polymerase, and 0.075 [jlM of each 
primer (CH-1 and SI primers, see materials) were added in
5.0 fil of 10 x Thermophilic Buffer (500 mM KC1, 100 mM Tris- 
HC1 (pH 9.0), 1% Triton X-100) to a final reaction volume of
50.0 fxl. The other reaction conditions were the same as that 
in the "RT-PCR for clonal selection of the transfected 
cells" described previously.
14. Protein purification
Purification by WGA-Lectin chromatography
The WGA-coupled particles were equilibrated with PBS 
buffer, and then packed into a column (5 cm long with a 
diameter of 1.5 cm). The glycoproteins were initially 
isolated by WGA-Sepharose chromatography at 4°C. Typically,
150.0 ml of culture medium was collected, and then 
concentrated to a final volume of 40.0 ml by centrifugation 
4 times at 1500 x g with Centriprep-30 following manu­
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facturer's instruction. To protect the protein, proteinase 
inhibitors (as mentioned in Medium Collection) and sodium 
azide (0.1%) were added before the sample was applied to a 
WGA-Sepharose column equilibrated with PBS with 0.1% sodium 
azide. After washing with PBS for 4 hr at a flow rate about 
5 ml/hr, the absorbed fraction was eluted with 0.5 M N- 
acetylglucosamine in PBS (87] . In order to remove the 
suspended WGA lectin molecules, the eluted solution was 
passed through an anti-WGA immunoaffinity column (2 cm long 
and 1.5 cm in diameter) packed with anti-WGA immobilized 
Sepharose 6B particles. The preparation of the anti-WGA 
immunoaffinity chromatography was described as follows.
Preparation of anti-WGA ixnmunoaffinity chromatography
One milligram of antibody was dissolved in 1.5 ml of 
coupling buffer (50.0 mM sodium acetate, pH 5.5), purified 
and washed three times with coupling buffer by ultra­
filtration (Centricone, Amicon). To oxidize the carbohydrate 
moieties on IgG, the antibody solution was incubated at room 
temperature in the dark for 1 hr by adding One-tenth volume 
of NaI04 solution (25.0 mg/1.2 ml) .
The oxidized IgG was purified by Sepharose 10 column 
(Econo-Pac 10 DG column, Bio-Rad, 2.0 cm diameter, 5.0 cm 
long) as manufacturer's instruction. Right before use, the 
column was washed with 20.0 ml of coupling buffer, and then 
exactly 3.0 ml of IgG solution was added to the column. The
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column was eluted with coupling buffer. The first 3.0 ml of 
eluent was discarded and then 0.5 ml fractions were 
collected for 5 ml total elution. The optical absorbance of 
every fraction was measured at 280 nm. The first peak 
fractions were collected. The Sepharose 10 column was re­
generated by at least 20 ml of coupling buffer and stored in 
coupling buffer with 0.02% of sodium azide.
After 1.5 ml of "affini-hydrazide gel" (affi-gel Hz, 
Bio-Rad) was washed twice with 10 ml of coupling buffer in a 
polypropylene tube, the prepared IgG was added directly into 
the washed gel and incubation was performed for 10-24 hr at 
room temperature by shaking gently.
The IgG-coupled gel particles were packed into a 
prepared column (1.0 cm diameter, 10.0 cm long), washed with 
1 volume of 0.5 M NaCl/PBS to remove the unbound IgG, and 
washed with ten bed-volumes of PBS before usage. For long 
term storage, the column was stored in PBS buffer with 0.02% 
of sodium azide.
Protein concentration
Centriprep and centricone (with a 30 kDa cut off 
range) were used for concentrating the protein solution 
before being applied onto the columns. The protein was 
concentrated by Centriprep-30 and Centricone-30 to suitable 
volume depending on the initial amount of sample used 
following manufacturer's instruction. In order to increase
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the efficiency of protein recovery, 3% BSA solution was used 
to pre-coat the membrane of the Centriprep-30 by centri­
fugation at 1500 x g for 15 min. The pre-coated Centriprep- 
30 was washed thoroughly with PBS twice by centrifugation at 
1500 x g for 15 min. For Western blot analysis, the re­
combinant glyprotein was isolated by the Centricone-30 
without the pre-treatment of BSA to prevent the cross­
reaction of suspended BSA with the antibody used. The final 
product of the recombinant glycoprotein was approximately 
concentrated to 1.0 mg/ml, aliquoted and stored by frozen at 
-80°C by adding 6.1% glycerol.
15. Protein assay
BCA protein assay was used to measure the quantity of 
the protein content as manufacturer's instruction (Pierce, 
Rockford, IL) [88].
BSA were prepared in PBS buffer from 100 /ig/ml to 1200 
Hg/ml and used as standards of the protein assay. The 
working buffer was prepared as manufacturer's instruction by 
mixing fifty parts of reagent A (bicinchoninic acid (BCA) 
solution) with one part of reagent B (4% copper sulfate 
solution). Each standard or unknown sample was pipetted in 
the amount of 25.0 fil into the appropriately labelled test 
tube, and PBS was used as a blank control. Then 500 ixl of 
working buffer prepared above was added into each tube, 
mixed well, covered with Saran wrap, and incubated at 37°C
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for 20 min. After incubation, all tubes were set on the 
bench to allow the solution cool down to room temperature. 
Exactly 200 fi 1 of solution was transferred from each test 
tube to microtiter plate. The absorbances at 570 nm were 
measured by microtiter plate reader. The concentration of 
protein was obtained by the absorbance and the linear 
equation of the standard curve.
16. ELISA
For the detection of hZP3 secretion from stably 
transfected cells, A rabbit polyclonal antibody (Ab5a) 
against a conserved oligopeptide sequence of ZP3 protein 
(PIECRYPRQGNVSS) which was amino acids 137-150 deduced from 
the DNA sequence among several species (human, mouse, and 
hamster) was used in ELISA. This antibody was a kind gift 
from Dr. Hinsch and was previously characterized by positive 
immunohistochemical staining in human oocytes and by Western 
blotting in vitro [45,46].
The production of the antibody was as follows: Five 
milligrams of peptide was dissolved in 500 fi 1 of distilled 
water, added to 10.0 mg of KLH (keyhole limpet hemocyanin), 
dissolved in 1.5 ml sodium phosphate buffer, pH 7.0, and 
mixed with 0.5 ml of 10.0 mg/ml EDC (1-ethyl-3-(3-dimethyl- 
aminopropyl) carbodiimide hydrochloride). The pH was 
maintained at about 5.1 for 1 hr. Then an additional 0.5 ml 
of 10.0 mg/ml EDC was added, and the mixture was incubated
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for 24 hr at room temperature. The conjugate was dialyzed 
against 15 1 of distilled water for 24 hr, lyophilized, and 
stored desiccated at -20°C. Female New Zealand rabbits were 
inoculated intradermally with 1.0 mg of the conjugate and 
antisera were collected. For affinity purification of 
antibody, peptide used for immunization was coupled to an 
AminoLink affinity column, and performed according to 
manufacturer's instruction [45].
Samples and controls were coated to a microtiter plate 
(EIA grade, Costar) in 100 jttl aliquots at room temperature 
for 9 hr in a humid atmosphere. The microtiter plate was 
washed six times with PBS by a 12-channel plate washer (Nunc 
well washer, Fisher) to remove the unbound antigen. The 
blocking buffer (0.2% Tween 20 in PBS buffer) was added and 
incubated for two hours in a humid atmosphere at room 
temperature. The plate was washed with PBS buffer, and then 
100 fi 1 of Ab5a (1:100 dilution in 0.2% Tween 20/PBS) was 
added and incubated for 1.5 hr. Horseradish peroxidase 
conjugated goat anti-rabbit IgG was used as second Ab (1:200 
dilution in 0.2% Tween 20/PBS), and was incubated for one 
hour. A 100 fil of tetramethyl-benzidine (TMB, Pierce) was 
added to each well, and incubated at room temperature for 5 
min for color development. The positive wells appeared pale 
blue. The reaction was stopped by adding 120 pi of 1.0 M 
H2S04, and the absorbance at 450 nm was measured.
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17. Metabolic labelling experiment
In order to distinguish the biosynthesized 
glycoproteins from the endogenous glycoproteins, a 3H- 
galactose metabolic labelling experiment was performed [89]. 
Transfected cells and non-transfected cells were split to 
15% confluence in MEM containing 10% FBS. The cells were 
cultured for 4 hr until attached to the plate surface, and 
then washed by PBS to remove the suspended cell-debris. The 
"radioactive" medium containing 250 fiCl of 3H-galactose was 
added, and cells was cultured for additional 16 hr. The 
medium was collected as described in previous section. 
Meanwhile, another portion of 5.0 ml of 3H-galactose medium 
was added into the cells for another 12 hr incubation.
The unincorporated 3H-galactose was removed from the 
collected medium by Centriprep with a 30 kDa cut-off range 
(1500 x g for 30 min). The retentate was washed three more 
time with PBS buffer (approximately, a total 40.0 ml of 
buffer was used for the washing). Both the retentate and the 
residual (washing) solutions were collected for further 
study. Another Spin was made to concentrate the retentate. 
The final volume was measured, and sodium azide with 
protease inhibitors were added immediately. The final 
retentate was adjusted to 2.0 ml by PBS. An aliquot of 5.0 
jj.1 solution in every samples (the retentate and washing 
solutions) was used to measure the radioactivity.
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One million cpm of metabolic solution (retentate) was 
passed through a wheat germ agglutinin (WGA) lectin column 
prepared as described previously, washed by ten bed volumes 
of PBS solution, and eluted by elution buffer (0.5 M N- 
acetylgalactosamine/PBS solution). Both of the WGA bound, 
and non-bound fractions were collected respectively. A 
suitable amount (10,000 cpm) of samples were loaded in SDS- 
PAGE gel with 4% stacking and 8% separation layers [81]. The 
SDS-PAGE was run with Tris-glycine buffer at 13 mA. The gel 
was fixed in 500 ml of methanol:acetic acid:water (25:10:65) 
for 30 min, soaked in 200 ml of "enhancer" solution 
(Amersham) for 30 min, and then dried by heating under 
vacuum for 1 hr. Autoradiography was performed as described 
before. In general, it took one week for the gel exposure to 
X-ray film at -80°C before development.
18. Silver-staining of SDS-PAGE
SDS-PAGE was prepared with a 10% separating gel and a 
4% stacking gel [81]. The protein samples was added by 1 
volume of a loading buffer containing 2% SDS, 10% glycerol, 
10% beta-mercaptoethanol, 0.001% bromophenol blue and 100 mM 
dithiothreitol in 50.0 mM Tris, pH 6.8, was used. After 
heating the samples at 100°C for 2 min, electrophoresis was 
run with Tris-Glycine buffer (pH 8.3) at 100 volts until 
the dye reached the bottom of the gel [81]. The gel was 
incubated at 4°C overnight in fixing solution (40% methanol/
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10% acetic acid), and then in 10% ethanol/5% acetic acid 
twice for 30 min each time.
The oxidizer reagent and silver reagent are prepared 
according to manufacturer's instruction (Bio-Rad) by 
diluting the concentrate solution ten times with deionized 
distilled water before use. The Development solution was 
also prepared according to manufacturer's instruction.
The gel was oxidized by prepared oxidizer reagent for 
10 min with gentle shaking, washed three times with 
deionized distilled water for 10 min each time, and then 
incubated at room temperature for 30 min with prepared 
silver reagent by shaking gently. The gel was washed again 
with deionized distilled water for 2 min with gentle 
shaking, and then developed by development solution until 
the solution turned yellow or until brown smokey precipitate 
appeared. The development solution was exchanged for another 
fraction of the same solution and incubated at room 
temperature by gentle shaking until the desired intensity 
was observed. The reaction was stopped by 5% acetic acid 
solution. The gel was washed in deionized distilled water 
for 10 min before photography.
19. Western blot analysis
SDS-PAGE with a 10% separating gel and a 4% stacking 
gel was performed as described previously [81] , using a 
minigel system (Hoefer Scientific, San Francisco). Wet
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transfer of protein was performed at 63 volts for 14 hr in 
transfer buffer prepared by adding 5.8 g Tris, 1.0 g SDS, 
29.0 g Glycine, and 200 ml methanol in 1 1 of water [79]. 
After transfer, the membrane was blocked with blocking 
buffer (0.2% Tween 20 in PBS buffer) for 2 hr by gentle 
shaking. The membrane was aligned onto a Deca-probe incu­
bation manifold (Hoefer).
Then 1.5 ml of the Ab5a (1:50 dilution in 0.2% Tween 
20/PBS) was added and incubated at room temperature for one 
hour by shaking gently. The membrane was washed three times 
with washing solution (0.2% Tween 20/ PBS) for 5 min each to 
remove unbound antibody. A second antibody solution (bio- 
tinylated goat anti-rabbit IgG) and "ABC solution" (Avidin 
DH and biotinylated alkaline phosphatase H) were prepared in 
washing solution as manufacturer's instruction (Vector). The 
prepared second antibody solution was poured over membrane 
and incubation was continued for 30 min at room temperature 
with gentle shaking. The membrane was washed three times 
with washing solution for 5 min each to remove unbound 
second antibody. The previously prepared "ABC" solution was 
then poured over membrane, and incubation was performed with 
gentle shaking for 30 min at room temperature.
After another three washes with washing solution, the 
membrane was removed from manifold, and rinsed once in 
washing solution 2 (0.2% Tween 20, 150 mM NaCl, and 50.0 mM 
Tris, pH 7.5), and then soaked in another aliquot of the
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same solution with agitation for 5 min. The membrane was 
washed twice with washing solution 3 (150 mM NaCl, 50.0 mM 
Tris, pH 7.5) for 2 min. Meanwhile, BCIP/NBT solution was 
prepared as manufacturer's instruction (Vector). The immune 
complexes were visualized with BCIP/NBT in the dark for 5-30 
min until the satisfactory staining intensity depending on 
the amount of antigen loaded on the gel. Another Wash for 5 
min in water was made before photography. The stained 
membrane was dried and stored folded between two pieces of 3 
MM filter paper.
20. Hemizona assay
Human immature (prophase I) oocytes were stored in a 
hyperosmotic solution consisting of 1.5 M MgCl2 supplemented 
with 0.1 % polyvinylpyrrolidone (PVP) in 40 mM Hepes buffer 
(pH 7.3). Oocytes prepared in this manner can be stored at 
4°C for up to 90 days without loss of activity in the HZA. 
Before the assay, the oocytes were removed from storage and 
rinsed in Ham's F-10 medium. Narishige micromanipulators 
(Tokyo, Japan) mounted on a phase-contrast inverted 
microscope (Nikon Diaphot, Garden City, NY) are used for 
cutting the oocytes into matching hemizonae. A detailed 
protocol for the microbisection procedure and oocyte 
handling has been described.
Semen samples were provided by fertile men (donors) by 
masturbation after 3-5 days of sexual abstinence. Sperm were
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washed twice by Ham's F10 medium with 3.5% of human serum 
albumin (swim-up solution) and centrifuged at 400 x g for 
7 min and 5 min respectively. The sperm pellet was overlaid 
with 0.5ml of swim-up solution as described above for one 
hour at 37°C, and the upper fraction of motile swim-up sperm 
was collected for further experiment. The sperm numbers 
before and after swim-up procedure were counted for the 
preparation of sperm concentration.
For the HZA, two sperm suspensions were prepared: one 
was utilized as the control sperm (incubated at 37°C in 5%
C02 in air), while the other one was incubated under 
identical conditions but in the presence of the test 
substance (hZP3). Different given concentrations of hZP3 
were examined (60 min incubation time). After this 
incubation period, the sperm was subjected to a wash and 
centrifugation step to remove excess protein (control sperm 
are treated identically) . A 100 fxl sperm droplet from the 
control sperm was placed under previously equilibrated 
mineral oil, and incubated with a hemizona for 4 hr at 37°C 
in 5% C02 in air. A 100 fxl droplet of the test sperm 
suspension was incubated with the matching hemizona (from 
the same pair) under identical conditions. Following the 4 
hr incubation period, the hemizonae were rinsed in culture 
medium using a finely drawn glass pipette in order to 
dislodge loosely attached sperm. Thereafter, the number of 
spermatozoa tightly bound to the outer (convex) surface of
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each hemizona was counted employing phase-contrast 
microscopy (x 200) . For each assay, the HZA results were 
expressed as hemizona index (HZI) calculated as follows: 
numbers of sperm bound for test/control x 100.
Typically, the control sperm suspension was incubated 
in culture medium while the test sperm suspension was 
incubated with hZP3. Experiments were also carried out 
assaying control sperm (in Ham's F-10) versus test sperm 
exposed to the different cell transfection and protein 
separation conditions including: culture medium of non­
transfected cells and WGA non-bound fraction from the 
protein separation procedures. For each given condition 
tested in the HZA, 5-8 oocytes were used and binding results 
statistically analyzed by a paired t-test [90-107] .
21. Acrosome reaction assay
The acrosomal status of spermatozoa was evaluated 
using the fluorescent probe fluorescein isothiocyanate- 
labeled Pisum Sativum agglutinin (FITC-PSA) following 
previously described techniques. Assay slides were read 
using an epifluorescent microscope at 400 x magnification; 
duplicate slides were evaluated for each treatment and time 
analyzed, assessed blindly by two different experienced 
observers and results averaged. At least 100 cells were 
evaluated per slide. Acrosome reacted sperm were diagnosed 
when a total loss of the acrosomal cap was observed (bar
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pattern), or no immunofluorescence was seen at all.
Acrosome-intact sperm typically show staining of the entire 
acrosomal cap [29-35,108].
The acrosomal status of control and test (rZP3- 
treated) sperm was initially examined under basal conditions 
(spontaneous acrosome reaction). Different concentrations of 
rZP3 were assessed. In addition, sperm motility was 
evaluated by the aid of a semen computer analyzer (Hamilton- 
Thorn, Beverly, MA).
22) Statistical analysis
The results of the Hemizona assay (test versus 
control) were analyzed by paired t-test by the aid of 
computer (CSS, Statistica). The formula for paired t-test is 
as follows:
Where Sj and s2 are the standard deviations of the test 
and control groups respectively,and n, and n2 are the number 
of samples in test and control groups respectively. (X,-X2) 
represents the difference between the means of the two 
groups. The term (/z,-/z2) is based upon the null hypothesis, 
which assumes that the two populations are not different and 
therefore the difference is equal to zero. So (/Z]-/x2) = 0.
The term r is the correlation coefficient, and the 
formula is as follows:
t =
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Where X and Y represents the score in test and control 
group respectively, and n is the number of pairs of scores.
The results of the paired t-test were scored by the t 
and p values. The larger the t score is and the smaller the 
p score is, the more significant the results are [103,109].
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IV. Results
A. Subcloning of the full-length cDNA of human ZP3
Dean reported that in the mouse, the expression of 
hZP3 protein is highly restricted to the growing oocyte 
[39,40]. We obtained total RNA from fresh, surgically 
removed human ovary using Chirwin's guanidinium thiocyanate 
extraction method [80]. The result of the extraction was 
confirmed by the observation of the sharp bands of the 28 S 
and 18 S rRNAs that appeared on agarose gel. This was 
followed by isolation of polyadenylated mRNA by using the 
biotin-labeled oligo(dT) and avidin-bound polymagnetic 
particle method.
A pair of primers (CH-1 and CH-2 primers) was designed 
based on the reported sequence of hZP3 [40] . Results of the 
restriction digestion and the length of produced cDNA from 
the RT-PCR are shown in Fig 3. The full length and the 
restriction digestion fragments of the RT-PCR product are 
exactly as expected [40], suggesting that the RT-PCR product 
may be a full length cDNA of hZP3 and that the amplification 
is completely specific because there was only one single 
band found. In order to further identify the RT-PCR product, 
a 21 bases internal probe (SI primer) was designed to
58
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Fig 3. Restriction digestion analysis of the RT/PCR product.
(A) After mRNA was isolated from the ovary, RT-PCR was 
performed and the product (cDNA) was identified by 
restriction mapping. The produced RT/PCR product is 
probably the full length cDNA of hZP3 (1278 bp) 
estimated according to the 123 DNA marker (ladder) based 
on that difference between every band in the marker is 
123 base-pairs. In addition, three restriction enzymes 
were used: Seal, BstXI, and MvnI. The restriction 
mapping was matched with hZP3 as expected. The 401 bp 
band in MvnI digestion; 156 bp and 142 bp bands in 
BstXI; 51 bp band in Seal can not be seen in this figure 
due to low intensity.
(B) Scheme for the restriction digestion.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
5 9
1





•S' S5 «  KS T  °  S  2*  c n i lsgsss
s r
5' — --- ----- --- --------------------
1
Seal BstXI BstXI MvnI 
48 153 296 398
Seal : 1229, 51 
MvnI : 880, 401 
BstXI: 983, 156, 142
B
<—  1278 
*—  983 
«—  880
1278
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
6 0
specifically recognize the cDNA of human ZP3 [40,65]. This 
probe was labelled with 32P-ATP and hybridized to the intact 
cDNA and its restriction digested fragments, and visualized 
by autoradiography (Fig 4). The results of Southern blot 
analysis were exactly as expected. The RT-PCR product (cDNA 
solution) was directly purified by phenol extraction and 
stored at 4°C.
For further application, the purified RT-PCR product 
(hZP3 cDNA) was inserted into the PSK (pBluescript SK) 
vector, and then the hZP3/PSK construct was introduced into 
XL-l Ecoli [7,71] . Approximately 100 clones were selected by 
color selection as described in the Methods. DNA was 
extracted from each individual clone of the positive ones, 
and further selection and identification were fulfilled by 
restriction mapping, Southern blot analysis and PCR using an 
internal probe (SI primer)(Fig 5 and Fig 6). Seven clones 
demonstrated expected pattern of restriction digestion and 
Southern blot analysis (Fig 5) .
Polymerase chain reaction (PCR) was performed to 
further identify the selected clones by using two pairs of 
primers (CH-l/CH-2 and CH-1/S1) as shown in Fig 6. The 
results demonstrated single band amplification at the 
expected sites by CH-l/CH-2 and CH-1/S1 primers (Fig 6).
Both linear and circular DNAs from selected transformed 
clones (hZP3/PSK DNA construct) were used to identify the 
correct insertion of the cDNA of hZP3 into the PSK vector.
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Fig 4. Southern blot analysis of the RT-PCR product.
(A) Restriction digestion analysis of the RT-PCR product 
(left), and Southern blot analysis by an internal probe 
SI (see materials) (right). The same three restriction 
enzymes were used: BstXI, Seal, and Sail. The 
restriction mapping was matched with the cDNA of hZP3 as 
expected, and the Southern blot analysis demonstrated 
the hybridizations at the right sites further identified 
the RT-PCR product as cDNA of hZP3.
(B) Scheme and results for the restriction digestion and 
Southern blot analysis.
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Fig 5. Identification of the hZP3/PSK construct by-
restriction digestion and Southern blot analysis.
(A): Restriction digestion analysis of the hZP3/PSK DNA 
construct. EcoRI, Smal, Sail, and BamHI/XhoI were used 
for the restriction digestion.
(B): Southern blot analysis of the same gel by using an 
internal probe (SI).
(C): Scheme for the restriction digestion of hZP3/PSK 
construct.
The cDNA of hZP3 (RT-PCR product) which was blunt-end 
ligated with EcoRI linkers, was inserted into PSK 
vector for the purposes of clone selection, amplifi­
cation, long-time storage, and further identification. 
The ligated product of the hZP3/PSK construct was 
transformed into XL-1 bacteria; clone selection was 
made on the agarose plate by color selection and 
restriction mapping analysis of the isolated plasmid 
DNA (hZP3/PSK construct) was performed.
The scheme for the restriction digestion analysis of 
the isolated plasmid DNA of hZP3/PSK construct and the 
expected results of the restriction digestion and 
Southern blot analysis were shown.
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Fig 6. PCR of the cDNA of hZP3 by an internal probe SI.
(A) DNAs from selected transformed clones (hZP3/PSK DNA 
construct) were used to identify the correct insertion 
of the cDNA of hZP3 into the PSK vector. Two pairs of 
primers were used for this identification : CH-l/CH-2, 
and CH-1/S1. A specific amplification of a 1278 base- 
pairs product by using CH-1 and CH-2 primers, and a 954 
base-pairs product by using CH-l and SI primers were 
observed.
(B) Schemes for the PCR method: the identification of the 
insertion of the hZP3 cDNA into the PSK expression 
vector.
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The linear DNA was produced by restriction digestion and 
purified by the gene-clean glassmilk method.
To further verify the cloned cDNA as hZP3 cDNA, 
autosequencing was performed by taking advantage of the T3 
and T7 promoters inherent in the PSK vector [110] and the 
sequence obtained was compared with the sequence published 
by Dean (Appendix I).
Based on the computer print-out, a total of 289 bases 
was identified from the 3'-end of hZP3 cDNA by taking 
advantage of the T3 promoter and a more than 98% homology 
was found with the sequence of hZP3 cDNA reported by Dean 
(Fig 7 and Appendix III). A gap was found (base 196-186) and 
mis-matched bases were located at the following positions: 
331, 314, 310, 284, 289 and 262. However, the sequence under 
the big T peak of the gap was found identical to the 
published sequence except base 186 and base 196. An extra T 
base (base 196) was read mistakenly by the sequencer due to 
the large T signal (Appendix III). The mis-matched bases at 
position 331, 284, 289 and 262 were found to be machine 
error. The sequencer did not recognize the right bases 
because the peaks fell just outside the window of detection 
set by the technician. The other extra bases obtained (base 
363, 353, 349, 345, 298 and 290) were found to be read 
mistakenly due to low intensity of signals. The deletion at 
base 84 was definitely a machine error because it was 
located right inside the sequence of CH-2 primer used for
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Fig 7. Comparison of the sequence of hZP3 cDNA from the 3'- 
end sequencing.
(A): 3'-end sequence of our cloned hZP3 cDNA. The numbers 
labelled are according to the print-out result of 
autosequencing for the convenience of comparison (see 
also Appendix III).
(B) : 3'-end sequence of the hZP3 cDNA published by J.Dean.
The numbers labelled are according to the published 
sequence (See also Appendix I).
(C): Scheme for the 3'-end autosequencing of cDNA of hZP3. 
The cDNA of hZP3 (RT-PCR product) inserted into the PSK 
vector was further identified by DNA sequencing. DNA 
sequencing was achieved from 3'-end of the cDNA of hZP3 
by using T3 primer.
Two hundred eighty nine bases of hZP3 cDNA were identified, 
and a more than 98% homology with Dean's published sequence 
was found. A gap located from base 196-186 was underlined by 
dashed periods. The matched bases were represented by large 
letters, and the mis-matched ones were represented by small 
letters. The mis-matched bases were located at the following 
positions: 331,314,310,284 and 262 (according to the print­
out result of autosequencing).




370 NNGTTCNCNT NAGGNCCCTC CTCTCTGNAN 341
990 AGGTTCG-GT AAGGTCC-TC C-CTC-GGAG 1015
340 TACANTACTt NNTCACCAGG TCCNGAtGNN 311
1016 TACAGTACTc GGTCACCAGG TCCAGAcGAA 1045
310 cGGCANTGGC GTCCNGTACA TtTGTCaTCN 281
1046 gGGCATTGGC GTCC-GTACA -cTGTCtTCT 1073
280 TCNTCAACAG NGGCACCCtG GTGACTAGAA 251
1074 TCGTCAACAG TGGCACCCcG GTGACTAGAA 1103
250 GGACCTGTCC TCCCCACTGG TACTTCATCT 221
1104 GGACCTGTCC TCCCCACTGG TACTTCATCT 1133
220 CGTCACCCGN AACGGAAGAC TGTGTNTTTT 191
1134 CGTCACCCGA AACGGAAGAC TGTG-GAGTC 1162
190 TTTNTNACGA CCCGCATCCG GACCGACACC 161
1163 ACCACGACGA CCCGCATCCG GACCGACACC 1192
160 ACGACAGGGA CTGAGACTGA CGACAATAGG 131
1193 ACCACAGGGA CTGAGACTGA CGACAATAGG 1222
130 ACCAAGAGTG GTCCTCCACA GCGTGACGGA 101
1223 ACCAAGAGTG GTCCTCCACA GCGTGACGGA 1252
100 GGGTGGGACA CAGACG-AGG CTTATT 76
1253 GGGTGGGACA CAGACGAAGG CTTATT 1278
T3
? T 7 ^
4 T3 £
(C)
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PCR (see Appendix I and Materials).
By taking advantage of the T7 promoter, 224 bases were 
identified from the 5'-end of hZP3 cDNA and a more than 91% 
homology was found with the sequence published by Dean (Fig 
8 and Appendix IV). A 15 bases gap was found (base 182-196), 
and the sequence under the big T peak of the gap was found 
identical to the published sequence except base 191, 192 and 
193. In addition, two extra T bases were read mistakenly by 
the sequencer due to the large T signal (Appendix IV). Due 
to the low intensity of signals, the mis-matched bases after 
the position 228 (11 bases in a total of 15 bases) may be 
due to machine error as mentioned above. The other extra 
bases obtained (base 255, 261, 266, 279 and 286) were read 
mistakenly by the same reason.
In order to express the cloned hZP3 cDNA in PA-1 cell, 
the cDNA was subcloned into a mammalian expression vector 
(pREP4). The pREP4 vector is mainly composed of a Rous 
sarcoma virus long terminal repeat (RSV LTR) as upstream 
promoter, Epstein Barr virus OriP element (EBV OriP), EBNA-1 
gene, SV40 poly A element and the hygromycin resistance gene 
[81]. Restriction mapping and Southern blot analysis were 
again performed to identify the correct clones of human ZP3 
cDNA (Fig 9). Due to the non-specific digestion of EcoRI 
("star" activity), an extra fragment of 400 bp appeared in 
the restriction mapping. By using an internal probe (SI), 
the Southern blot analysis demonstrated that this non-
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Fig 8. Comparison of the sequence of hZP3 cDNA from the 5'- 
end sequencing.
(A): 5'-end sequence of our cloned hZP3 cDNA. The numbers 
labelled are according to the print-out result of 
autosequencing for the convenience of comparison (see 
also Appendix IV).
(B) : 5'-end sequence of the hZP3 cDNA published by Dean. The
numbers labelled are according to the published 
sequence (see also Appendix I).
(C) : Scheme for the 5'-end autosequencing of cDNA of hZP3.
The cDNA of hZP3 (RT-PCR product) inserted into the PSK 
vector was further identified by DNA sequencing. DNA 
sequencing was achieved from 5'-end of the cDNA of hZP3 
by using T7 primer.
Two hundred twenty four bases of hZP3 cDNA were identified 
and a more than 91% homology with Dean's published sequence 
was found. A gap located from base 182 to 196 was underlined 
by dashed periods. The matched bases were represented by 
large letters, and the mis-matched ones were represented by 
small letters. The different bases (mis-matched ones) were 
located at the following positions: 170, 173, 201, 208, 228, 
231, 238, 246, 247, 249, 250, 259, 260, 270 and 293 
(according to the print-out result of autosequencing).




66 ACCATGGAGC TGAGCTATAG GCTCTTCATC 95
1 ACCATGGAGC TGAGCTATAG GCTCTTCATC 30
96 TGCCTCCTGC TCTGGGGTAG TACTGAGCTG 125
31 TGCCTCCTGC TCTGGGGTAG TACTGAGCTG 60
126 TGCTACCCCC AACCCCTCTG GCTCTTGCAG 155
61 TGCTACCCCC AACCCCTCTG GCTCTTGCAG 90
156 GGTGGAGCCA GCCAcCCcGA GACGNCTTTT 185
91 GGTGGAGCCA GCCAtCCtGA GACGTCCGTA 120
186 TTANTTTTTT TCNGGaGGAG NNcCAGGAGG 215
121 -CAG-CCCGT ACTGGtGGAG TGtCAGGAGG 148
216 CCACTCTGAN GGcCAcNGNN AGtANNGACC 245
149 CCACTCTGAT GGtCAtGGTC AGcAAAGACC 178
246 caNaaGNNAA CCNccTAAGC CNCAcCANGG 275
179 ttTttGGCA- CCGgg-AAGC -TCAtCAGGG 205
276 CTGNNTGNCC CNCACCTcNG N 296
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Fig 9. Restriction digestion and Southern blot analysis of
the hZP3/pREP4 construct.
(A) Left: Restriction digestion analysis of the hZP3/pREP4 
DNA construct. RI, Rl/Scal, and Rl/Sall were used for 
the restriction digestion. Rl/Scal digestion was 
performed with two restriction enzymes: RI and Seal ; 
Rl/Sall digestion was performed with RI and Sail.
(A) Right: the Southern blot analysis of the same gel with 
an internal probe SI.
(B):Scheme for the restriction digestion analysis of the 
hZP3/ pREP4 construct.
The hZP3/PSK DNA construct was amplified in bacterial 
cells, isolated by guanidine thiocyanate method and 
purified by the maxi-prep method (spin column, Promega) ,- 
then it was ligated into a mammalian expression vector 
(pREP4) at the restriction cutting sites BamHI and Xhol. 
SI* which represents the radioactive-labelled internal 
prob SI is also shown in this figure.
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specific cutting site was located inside the pREP4 vector, 
because a 1278 bp fragment resulted from the cDNA of hZP3 
was the only one band hybridized.
Therefore, by using five different identification 
criteria based on length of the produced RT-PCR product, 
restriction mapping, Southern blot analysis, autosequencing 
and PCR, we have convincing evidence that the cDNA of human 
ZP3 was correctly amplified by our designed RT-PCR protocol 
and cloned into the PSK and pREP4 expression vectors.
B. In vitro transcription/translation
In vitro transcription/translation was performed to 
ensure the capacity of the cloned cDNA for producing a full 
length non-glycosylated hZP3 product. The TNT Coupled 
Reticulocyte Lysate System used bypass many steps in the 
standard rabbit reticulocyte lysate translation process by 
incorporating transcription directly in the translation mix.
The sequence between the open reading frame of the 
cDNA of hZP3 and the T3 promoter of the hZP3/PSK DNA 
construct had been checked and no additional translation 
starting site (i.e. ATG) found.
A hZP3/PSK DNA construct with the correct orientation 
insertion of hZP3 (5'-> 3',see Fig 10) was used as the test 
sample for in vitro transcription/translation. According to 
the manufacturer's instruction, 35S-methionine was used with 
the TNT Lysates for the purpose of autoradiography. A 47 kDa
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Fig 10. In vitro transcription/translation of the hZP3 
(nonglycosylated) protein.
(A) An 47 kDa protein was produced in the reticulocyte 
lysate system by taking advantage of the T3 promoter 
inherently present in the PSK vector. T3 RNA polymerase 
was added for the transcription of the inserted DNA.
[35S] -methionine was substituted in the reaction for the 
later autoradiography. In addition, Luciferase cDNA was 
used as a positive control, and the hZP3/PSK construct 
with the opposite orientation of insertion of the cDNA 
of hZP3 was used as a negative control.
(B) The protein marker was cut off from the gel and stained 
with Coomassie brilliant blue.
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product was produced by the cloned cDNA of hZP3 with 5'-> 3' 
orientation insertion. However, the DNA construct with the 
opposite orientation insertion (3'-> 5') was used as a 
negative control and nothing was found by the same appli­
cation. In addition, luciferase cDNA was used as a positive 
control according to manufacturer's instruction (Fig 10).
This result indicated that a full-length 
nonglycosylated hZP3 (47 kDa) was produced in the TNT Lysate 
reaction (transcription and translation) by using the cloned 
cDNA construct as template, and there was no reading frame 
shift because of the point mutation in the sequence of the 
cloned cDNA. Another protein which may be due to the non­
completed transcription or translation reaction was also 
observed with the molecular mass at about 40 kDa (Fig 10).
C. Stable transfection
A stable transfected human ovarian cell line was 
established by the CaP04-mediated transfection method 
[77,78,81,111], followed by antibiotic selection (hygro- 
mycin) for three weeks [76,84,85]. Since the quality of the 
DNA used and the particle size of the DNA produced by CaP04 
precipitation were critical for the efficiency of the 
introduction of the DNA construct into the host cells by 
phagocytosis [81], the supercoiled hZP3/pREP4 DNA construct 
was purified by CsCl gradient ultracentrifugation as 
described previously. Approximately, 200 single colonies
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were isolated by cloning rings [75].
PCR was used to identify the integration of the 
inserted cDNA of hZP3 into the genomic DNA by using CH-1 
primer and an internal primer (SI) (Fig 11) . In order to 
quickly isolate genomic DNA from a large number of clones, 
Higuchi's method was used as described in the Methods [86] . 
The transfected cell clones demonstrated a very strong 
specifically amplified product at the expected position 
(954 bp) on the gel, but not in the non-transfected cells as 
well as the cells transfected by vector only (pREP4 only, 
without cDNA of hZP3) . A total number of 12 clones were 
identified as transfected cells by this method. The high 
background resulted from (1) the complexity of genomic DNA 
in the host cell, (2) the inherent hZP3 gene in the PA-1 
cell (Appendix VIII) , and (3) the PCR conditions used. By 
Higuchi's method, the individual genomic DNA was isolated 
conveniently from a huge number of clones and the cell 
lysates with a lot of impurity were used directly as samples 
for PCR. Therefore, the conditions for PCR were not 
optimized and resulted in high background.
After knowing that the hZP3 cDNA was integrated into 
the genomic DNA in the transfected cells, the RT-PCR was 
performed to further identify the expression of the inserted 
cDNA by using the same pair of primers (CH-1/S1 primers) . As 
can be seen in the Fig 12, only the transfected cells were 
found to show distinct specifically amplified product. The
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Fig 11. Identification of the insertion of hZP3 cDNA into 
the transfected PA-1 cells by PCR.
Identification of the introduction of hZP3 cDNA into the 
genomic DNA of the host cell, PA-1, from the selected stable 
transfected cell clones, SKC-P3-15, SKC-P3-23, SKC-P3-19, 
and SKC-P3-12 by using CH-1 and an internal primer SI as 
shown at the bottom of the figure. A 954 base-pairs of 
specific amplification was observed in the transfected 
cells. The non-transfected cell and transfected cell with 
vector only were used as negative controls. The background 
bands were thought to be due to the high complexity of the 
genomic DNA, the endogenous hZP3 gene, and mostly the non­
optimized PCR conditions (see also Fig 15).
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Fig 12. Identification of the expression of hZP3 mRNA from 
the stable-transfected cell clones by RT-PCR.
The RT-PCR results of the stable transfected cell clones, 
SKC-P3-12, and SKC-P3-19 by using the same pair of CH-1 
primer and an internal primer SI as shown at the bottom of 
the figure. A 954 base-pair product was observed from the 
transfected cells, but not in the cells transfected with 
vector only. In addition, RNA sample without being 
transcribed by RT reaction was also performed by PCR as 
another negative control.
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cells transfected by vector only (pREP4, without insertion 
of cDNA of hZP3) did not show any RT-PCR product (Fig 12) . 
This result indicated that the hZP3 cDNA was expressed in 
the transfected cells, and little or no hZP3 mRNA was 
detected in the cells transfected with vector only.
In order to identify the production and secretion of 
recombinant ZP3 protein in the transfected cells, ELISA was 
performed as described in the Methods. The polyclonal anti­
body (Ab5a) used for ELISA was produced against a conserved 
oligopeptide (epitope) of ZP3 protein among several species 
(human, mouse, and hamster) [45] . This antibody was 
previously proven to be effective for the recognition of 
human zona pellucida proteins (ZP3, specifically) in 
immunohistochemical studies and in Western blot analysis 
[45,46]. As shown in Table 1, the results of ELISA 
demonstrated the present of hZP3 protein secreted in the 
culture medium of transfected cells compared to that of the 
cells transfected with vector only (negative control). The 
same oligopeptide which was used to produced the antibody 
was coated on microtiter wells as a positive control. Two of 
the transfected cells (SKC-P3-12 and SKC-P3-19) that showed 
the highest absorbance at 540 nm by ELISA were chosen for 
further application.
After several experiments, the background of the ELISA 
by using the Ab5a was high (Table 1), implying there were 
cross-reaction of this antibody with proteins other than
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Table 1. Identification of protein secretion of the stable- 
transfected cell clones by ELISA.
A polyclonal antibody (Ab5a) which was produced against a 
conserved oligopeptide epitope of hZP3 was used to monitor 
the secretion of hZP3 protein in the culture medium. The 
original oligopeptide (see Methods) was used as positive 
control; and the culture medium from cells transfected by 
vector only was used as a negative control. The average 
value of four absorbance reading at 540 nm in every sample 
was shown in the Table. The high background reading of the 
negative control implies the possibility of cross-reactivity 
of the polyclonal antibody with proteins other than hZP3.
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pREP4 vector only oligopeptide stable transfected
as as cell clones
negative control as positive control SKC-P3-12 SKC-P3-19
OD$4o 0.293 0.465 0.396 0.371
N=4
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hZP3. Therefore, various blocking buffers including BSA, 
Superblock (Pierce), Blotto, and Tween 20 in PBS buffer were 
tested (data not shown). The cross-reactivity of Ab5a was 
found to be strong when BSA and Superblock were used, and 
moderate when Blotto was used. The non-protein reagent,
Tween 20 (0.2% in PBS buffer) was finally determined to be 
most useful for the blocking process in the Western blot 
analysis.
D. Isolation and identification of the recombinant hZP3
For the purpose of the recombinant hZP3 production, 
two of the stable transfected cell clones (SKC-P3-12 and 
SKC-P3-19) which demonstrated the largest amount of hZP3 
secretion by ELISA were cultured and the culture medium was 
collected as described in Methods. Size-exclusion chroma­
tography (Sepharose-6B) and Lectin chromatography were 
performed to isolate the recombinant hZP3 in the culture 
medium. After several experiments, WGA was found to be more 
specific to hZP3 than Con A (Data not shown), and then size- 
exclusion chromatography was performed and found not 
effective due to the close molecular weight of the eluted 
glycoproteins.
WGA-Sepharose chromatography was finally determined to 
be used to isolate the recombinant hZP3 glycoprotein for the 
further applications. After the sample was applied to the 
WGA-Sepharose column and incubated at 4HC overnight, PBS
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buffer was used to wash the unbound molecules away and then 
N-acetyl glucosamine was used as a competitor to the WGA- 
particle in the Lectin column to elute the bound fraction as 
shown in Fig 13. In addition, to prevent the influence of 
residual lectin molecules with the bio-assay, the anti-WGA 
immunoaffinity chromatography was followed to remove the 
suspended WGA molecules in the eluted fraction. The final 
product was concentrated and stored as described before. 
Typically, an approximate 3 mg of total glycoprotein was 
isolated from 150 ml of the culture medium. SDS-PAGE and 
Western blot analysis were performed to identify the re­
combinant hZP3 protein in the WGA-purified glycoprotein 
solution. First of all, proteins were separated by SDS-PAGE 
and silver-stained as described in Methods and the results 
were shown in Fig 14. Five solubilized zonae pellucidae 
(from human oocytes) were also loaded on the gel and the 
silver staining demonstrated a strong wide band at about 65 
kDa, suggesting the molecular mass of hZP3 may be 65 kDa. 
Both the cells which are not transfected and the transfected 
cells indicated the major band at the same molecular weight, 
suggesting that there were proteins other than hZP3 with the 
similar molecular weight in the non-transfected medium. In 
addition, the 65 kDa band in the non-transfected medium was 
stronger than that in the transfected medium because of the 
following two reasons. First, more bands were observed in 
the transfected medium (Fig 14) , indicating more kinds of
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Fig 13. Isolation of the recombinant hZP3 glycoprotein by 
WGA-Sepharose chromatography.
Culture medium was collected and concentrated by Centriprep- 
30 as described in Methods. The concentrated solution was 
applied to the WGA-Sepharose column, PBS was used to wash 
the WGA-absorbed glycoproteins and then 0.5 M N-acetyl- 
glucosamine was used to elute the WGA-absorbed glycoprotein.
(1): WGA-unbound fraction (washed out by PBS)
(2) : Starting point for the N-acetylglucosamine elution
(3) : Peak of the WGA-absorbed fraction (WGA-purified
glycoproteins)
(4): Basal reading of the elution solution
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Fig 14. Separation of the recombinant hZP3 protein by SDS- 
PAGE.
Left: 50 ng of WGA-absorbed glycoproteins from non-trans-
fected cells and transfected cells were loaded onto a 
denaturing SDS-PAGE gel.
Right:Solubilized proteins from five human zonae were used 
for the identification of the molecular weight of the 
hZP3. Silver stain was performed for the purpose of 
visualization.
Both the transfected cells and non-transfected cells have 
the stained band at 65 kDa. Distinct bands between WGA- 
purified glycoproteins of transfected and non-transfected 
cells were observed, implying distinct glycoproteins were 
produced and secreted by the transfected cells.
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proteins were produced by transfected cells and therefore 
the intensity of each individual band was decreased. Second, 
in order to increase the recovery of glycoprotein, the 
Centriprep-30 used for the concentration was pre-coated with 
BSA solution. Therefore, there may be somehow more con­
tamination of residual BSA in the non-transfected medium 
from this process.
Since the silver-staining can not specifically 
identify hZP3 from the other proteins with the similar 
molecular weight, Western blot analysis was performed. As 
shown in Fig 15, the Western blot analysis with polyclonal 
antibody Ab5a (as mentioned in Methods), verified the band 
at 65 kDa as the recombinant hZP3. In addition, a second 
band hybridized at 100 kDa (or heavier) was also found by 
the Western blot analysis in the transfected culture medium. 
This suggested the possibility of heterogenous glycosylation 
of hZP3 protein in the transfected tumor PA-1 cells [45,46, 
77,78,111]. This will be discussed further in the later 
chapter. The solubilized zona pellucida was found hybridized 
at exactly the same position around 65 kDa '(Fig 15).
In order to identify the newly biosynthesized and 
secreted glycoproteins, a metabolic labelling study was 
performed by substituting [6-3H]-galactose in the culture 
medium of transfected cells and non-transfected cells as 
described in the Methods. The reasons for choosing this 
monosaccharide were: (1) Galactose is one of the major
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Fig 15. Identification of the secretion of the recombinant 
hZP3 protein by Western blot analysis.
One microgram of WGA-purified glycoproteins from non- 
transfected cells and transfected cells, and solubilized 
proteins from five human zonae were loaded onto SDS-PAGE. 
And a polyclonal antiserum against a conserved oligopeptide 
of ZP3 protein was used for the identification of hZP3. 
Distinct bands were found at 65 kDa and 100 kDa from 
transfected cells, and the solubilized human zonae proteins 
demonstrated a major band around 65 kDa.
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components (estimated at least more than 25%) of the complex 
type N-linked and O-linked oligosaccharides which are 
believed to be the major types of oligosaccharides in the 
hZP3 glycoprotein. [39,40,49,66-68,112-116]; and (2) there 
is less sugar conversion of galactose to other mono­
saccharides in vivo [89] .
The culture medium was collected and ultrafiltration 
was performed to remove the suspended 3H-galactose in the 
medium and PBS was used for the washing (totally, 40.0 ml 
were used). The final samples were concentrated to 
approximately 2.0 ml by Centricon 30 (Amicon). An aliquot of 
5.0 /il solution was taken from the retentates and washing 
solutions of both transfected cells and non-transfected 
cells to be monitored for radioactivity. The results are 
shown in Table 2. According to these results, the glyco­
proteins produced and secreted in the transfected cells were 
estimated 3.29 times higher than that in the non-transfected 
cells from the total radioactivity shown in the retentate 
solutions (Table 2) . Most of the 3H-galactose was left 
inside the cells (estimated more than 90% of the total 3H- 
Galactose used). Ten more million cpm of radioactivity was 
found in the washed solution (suspended 3H-galactose) of the 
non-transfected cells than that in the transfected cells, 
implying that there was ten more million cpm of radio­
activity left inside the transfected cells than that left 
inside the non-transfected cells. This also implied that
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Table 2. Summary of metabolic labelling experiment. 
3H-galactose was substituted into the culture medium of the 
transfected and non-transfected cells to study the 
biosynthesized glycoprotein. The culture media from non- 
transfected cells and transfected cells were centrifuged to 
remove the suspending cells, concentrated by Centriprep 
ultra-filtration with a 30 kDa cut-off, and washed by 40 ml 
of sterile PBS (total volume) to remove the remaining 3H- 
galactose in the medium. Five microliter of each sample was 
taken for the measurement of the radioactivity, and the 
results are shown in the table. The biosynthesized 
glycoprotein of the transfected cells was 3.29 times more 
than that of the non-transfected cells based on this 
calculation.
About 90% of the radioactivity was still left inside the 
cells. Less total radioactivity was found in retentate and 
washed solution of the transfected cells than that of the 
non-transfected cells implied that there were larger amount 
of processing glycoproteins insides the transfected cells 
than that in the non-transfected cells.












transfected retentate 8472 .2 2 ml 3.39 x 106
cell washed 3449 .3 40 ml 27.59 x 10°
non-transfected retentate 2562.0 2 ml 1.03 x 106
cell washed 4934.5 40 ml 39.47 x 10b
* Glycoprotein in transfected cell = 3.29 x Glycoprotein in 
non-transfected cell (after WGA isolation)
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there were still biosynthesized glycoproteins left inside 
the transfected cells (not secreted yet).
After the glycoproteins were purified by WGA-Sepharose 
chromatography from the culture medium of transfected cells 
and non-transfected cells, SDS-PAGE and fluorography were 
performed as described previously. As shown in Fig 16, 
distinct broad bands were found in the transfected medium at 
55-70 kDa (at least three bandings), 80 kDa, and 100 kDa 
(Fig 16) . Furthermore, on the same gel, the WGA-unbound 
fraction of protein solution (washed solution) from the 
culture medium of the transfected cells was also loaded, and 
most of the proteins were found at around 50 kDa and 80 kDa.
E. Biological activity of the recombinant hZP3
Sperm motility was examined by the assistance of a 
semen computer analyzer and no difference was found between 
test and control groups, implying that the WGA-purified 
recombinant protein solution did not have toxic effects on 
the sperm cells (Data see Appendix V).
The hemizona assay (HZA) was performed to characterize 
the biological activity of WGA-purified recombinant protein 
and the data were analyzed by a paired t-test (see also 
Appendix VI), and the results are shown in Fig 17. When WGA- 
purified culture medium of transfected cells (1:4 dilution, 
estimated 2.5 (ig/ml of rZP3) was tested against culture 
medium (Ham's F-10), a 49% inhibition in binding was
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Fig 16. Results of metabolic labelling experiment. 
3H-Galactose was substituted into the culture medium of the 
transfected and non-transfected cells to study the 
biosynthesized glycoproteins. The culture media from non- 
transfected cells and transfected cells were concentrated by 
Centriprep ultrafiltration with 30 kDa cut-off; the samples 
were purified by passing through WGA-Lectin affinity 
chromatography. Distinct bands were demonstrated at 55-70 
kDa (three bands), 80 kDa, and 100 kDa. In addition, the 
WGA-unbound fraction (washed solution) of the transfected 
medium was also loaded on the gel as reference.
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Fig 17. Characterization of the biological activity (sperm- 
binding) of the recombinant glycoprotein in the hemizona 
assay (HZA).
Paired t-test was applied to analyze the results of HZA. 
WGA-purified culture medium of transfected cells at (1:4 
dilution) and (1:8 dilution) were tested by the hemizona 
assay, and showed 49% inhibition (n=6, p<0.05) in binding 
with (1:4 dilution) sample, but no significant difference 
was observed with (1:8 dilution) sample.
Ham's F-10 and WGA-purified culture medium of non- 
transfected cells were used as negative controls.
The concentrations of total glycoproteins in WGA-purified 
culture medium of transfected cells and non-transfected 
cells were controlled at 1 mg/ml.
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observed and the results were statistically significant 
(n=6, p<0.05 by paired t-test) (Appendix VI). No significant 
differences were observed at a 1:8 dilution. This result 
demonstrated that there seems to be a concentration- 
dependent effect of the recombinant hZP3 in the HZA. In 
addition, the WGA-purified culture medium of non-transfected 
cells (both 1:4 and 1:8 dilution) did not show any 
inhibition (negative control) (Fig 17).
Furthermore, at a 1:4 dilution, the WGA-purified 
culture medium of transfected cells (rhZP3) produced a >50% 
induction of acrosome reaction (AR) after overnight 
incubation. Both Ham's F-10 and WGA-purified culture medium 
of non-transfected cells were used as negative controls 
(spontaneous AR). No difference was observed between the 
controls (20% basal AR were found) . A 10.0 /tM of calcium 
ionophore (A23187) was used as a positive control at the 
same conditions, and showed a similar effect to that 
achieved with a 1:4 dilution of WGA-purified transfected 
cells culture medium (about 70% AR were found).
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V. DISCUSSION AND CONCLUSIONS
Recent studies report ZP3 to be critical for the 
initiation of fertilization in the mouse model [9,39,117- 
120] . More studies on the human ZP3 protein need to be 
performed to prove relevance in the human system. However, 
it is difficult to study hZP3 due to: (a) the difficulties 
in obtaining enough material for research, and (b) the 
heterogeneity of glycosylation of its polypeptide backbone, 
which results in difficulty isolating the protein [40,42,
53] . Here we produce the hZP3 cDNA by RT-PCR and express the 
hZP3 glycoprotein in stable-transfected PA-1 cells by using 
molecular biology techniques, and taking advantage of the 
published sequence for hZP3 cDNA [40] .
A. Subcloning of hZP3 cDNA
In the mouse model, the expression of ZP3 is highly 
oocyte-specific and is restricted to the 2-weeks growth 
phase of oogenesis that occurs prior to ovulation [56,57,
60] . Therefore a fresh, surgically removed human ovary was 
used as source of the mRNA for the production of full-length 
hZP3 cDNA by RT-PCR. A single product was amplified by RT- 
PCR (Fig 3). The RT-PCR product was identified to be full 
length hZP3 cDNA by restriction mapping (Fig 3) , Southern
89
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blot analysis (Fig 4) , and PCR (Data not shown). Further 
studies indicated that it is indeed hZP3 cDNA and there is 
no reading frame shift, although there may be some point 
mutations in the sequence (Figs 7, 8 and 10).
The RT-PCR product (hZP3 cDNA) was first inserted into 
pBluescript SK (PSK) vector and then subcloned into an 
mammalian expression vector (pREP4). A subcloning strategy 
and methodology was developed based on blunt-end ligation 
with an oligonucleotide linker, and has been proven to be 
effective for the introduction of the RT-PCR products into 
vectors. There were many advantages to insert the cDNA into 
PSK vector as follows: (1) An in vitro transcription/ 
translation (by taking advantage of the T3 promoter inherent 
in the PSK vector) was performed to identify the capacity of 
the cloned cDNA to produce a full-length non-glycosylated 
hZP3 protein (47 kDa. Fig 10) . (2) Autosequening was
performed by taking advantage of the T3 and T7 promoters 
inherent in the PSK vector (Fig 7, 8; Appendices III, IV) .
(3) "Color selection" using the PSK vector and XLl-Blue 
Ecoli bacterial system enhanced the efficiency of clone 
selection. Restriction mapping, Southern blot analysis and 
PCR were performed to identify the right clone (Figs 5, 6).
In order to express the hZP3 in PA-l cells, the cloned 
cDNA was subcloned into appropriate mammalian expression 
vectors. We have successfully inserted the hZP3 into an 
episomal vector, pREP4, which is mainly composed of a Rous
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sarcoma virus long terminal repeat (RSV LTR), Epstein Barr 
virus OriP element (EBV OriP), EBNA-1 gene, SV40 poly A 
element and the Hygromycin resistance gene (Fig 9) . There 
are two major advantages by using pREP4 as vector to express 
foreign cDNA in mammalian cells. First of all, the RSV LTR 
is active in a broad range of mammalian cell types,• 
therefore, the foreign gene or cDNA inserted into the pREP4 
vector is capable of being transfected into and expressed in 
a variety of mammalian cells. Second, the inherent EBV OriP 
element and EBNA-1 gene maintain and allow the introduced 
vector to be propagated for the expression of foreign genes 
in adherent mammalian cells [81] .
B. Expression of hZP3
1. Stable transfection
The biological activity of the ZP3 (i.e. the receptor 
ligand ability) has been reported to be related to its 
carbohydrate side chains [28,40,48,49,98,100], therefore, 
the glycosylation of the protein is critical for the 
production of a recombinant hZP3 with biological function. 
Therefore, a human ovarian tumor cell line, PA-1, was 
selected as the host cell for the production of recombinant 
hZP3 glycoprotein based on three facts: (1) it is an ovarian 
cell line, (2) it is of human origin, and (3) it is known to 
produce glycosylated native proteins (lactosaminoglycan- 
carrier glycoprotein with 80-120 KDa molecular mass; and
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heparin-binding protein which is about 44 kDa) [77,78], and 
recombinant proteins (recombinant fibronectin) [111] .
After the cloned hZP3/pREP4 expression vector DNA 
construct was introduced into PA-1 cells by the calcium 
phosphate-mediated method and hygromycin selection, the 
single colonies of stable-transfected cells were identified 
and selected by three criteria: PCR (Fig 11), RT-PCR (Fig 
12), and ELISA (Table 1).
Based on the results, the expression vector construct 
was integrated into the genomic DNA of PA-1 cell, and might 
be integrated into the chromosomal DNA. First of all, a 
specifically amplified product (954 bp) was identified by 
PCR using CH-1/S1 primers in the transfected cells, but was 
not found in the non-transfected cells, suggesting the 
integration of the hZP3 cDNA into the genomic DNA (Fig 11). 
Second, total cytoplasmic RNA (as well as small DNAs other 
than chromosomal DNA) was isolated by the sucrose gradient 
method as described previously, and a single specifically 
amplified product was identified by RT-PCR using CH-1/S1 
primers in the transfected cells. However, nothing was found 
by the same application in the cells transfected with vector 
(Fig 12) or in the non-transfected cells (Data not shown). 
Therefore, no genomic DNA in the cytoplasm was amplified by 
PCR using CH-1/S1 primers, otherwise there ought to be some 
background observed in the RT-PCR identification (Fig 12). 
Third, it is believed that the introduced foreign DNA was
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not stable in the cytoplasm and ought to be digested by 
DNase inside the cells in a few days.
The mechanism of the integration of the expression 
vector DNA construct (hZP3/pREP4) into the chromosomal DNA 
of the host cells (PA-1) is not clear, but it is believed to 
be a non-specific integration. Nevertheless, the Rous 
sarcoma virus long terminal repeat (LTR) inherent in the 
expression vector (episomal vector, pREP4) is able to be 
inserted into the chromosomal DNA by transposition [121]. 
Therefore, the vector-dependent mechanism (Rous sarcoma 
virus LTR) may be responsible for the integration of 
hZP3/pREP4 construct into the PA-1 genomic DNA [121].
2. Expression of hZP3
The in vitro transcription/translation experiment 
demonstrated that our cDNA of hZP3 was able to produce a 
nonglycosylated protein which exhibited full-length protein 
backbone of the hZP3 glycoprotein (47 kDa. Fig 10). In 
addition, a second product with a molecular mass about 40 
kDa was also observed (Fig 10). We do not know whether this 
protein has any physiological meaning or just represents a 
non-completed product of the transcription or translation 
reaction.
In order to produce glycosylated hZP3, the cloned cDNA 
was introduced into and expressed in PA-1 cells. Culture 
medium was collected and the recombinant hZP3 was purified
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by WGA-Sepharose chromatography and anti-WGA immunoaffinity 
chromatography as described in Methods (Fig 13). Centriprep- 
30 and Centricone-30 were used to concentrate protein 
following manufacturer's instruction.
Although there were still many different glyco­
proteins, the WGA-purified glycoprotein solution showed the 
banding at the expected position (65 kD) by SDS-PAGE and 
silver staining (Fig 14). The SDS-PAGE by silver staining 
could not be effectively analyzed for the identification of 
the secreted hZP3 glycoprotein because of the following 
reasons. First, the test and control solutions were still 
composed of many proteins including some proteins with the 
similar molecular mass (65 kDa). Second, the amount of re­
combinant glycoprotein produced may not be enough for the 
identification. Finally, silver staining is not able to 
specifically identify the hZP3 from other proteins (Fig 14) .
Therefore, Western blot analysis with antibody (Ab5a) 
was performed and this further identified the hybridization 
at 65 kDa and 100 kDa (Fig 15). Moreover, solubilized human 
zonae demonstrated the exactly same size of hybridization at 
around 65 kDa by Western blot analysis, suggesting that hZP3 
is 65 KDa (Fig 15). In fact, a very weak band at 100 kDa was 
also hybridized in the solubilized zonae, suggesting this 
high molecular weight protein has less immunogenicity than 
the 65 kDa protein and may be related to hZP3.
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There are many possibilities for the 100 kDa (or 
heavier) glycoprotein which was produced by the transfected 
cells and also demonstrated immunogenicity in the Western 
blot analysis (Fig 15) . According to Shabanowitz, a band 
heavier than 100 kDa and in the similar position as ours was 
also hybridized by Western blot analysis when solubilized 
human zonae proteins were used as sample [53]. Shabanowitz 
explained this band may be a dimer of ZP1 and ZP2 [53] . In 
fact, it does not seem to be accurate if Dean's estimation 
about the molecular mass of hZP proteins is correct (hZP2 
about 76 kDa and hZPl about 100 kDa) [40]. More importantly, 
it does not agree with our understanding of the hZP proteins 
that ZP2 and ZP3 are believed to bind together as dimer, but 
not ZP1 and ZP2 [7,39] .
On the other hand, a transfected hamster ovarian cell 
line (CHO) was produced recently by the introduction of a 
hZP3 "minigene" construct [62]. The produced recombinant 
glycoprotein (55 kDa) was smaller than the native hZP3 and 
the most important biological activity of the hZP3, i.e. the 
sperm ligand activity, was not reported. Nevertheless, a 
band heavier than 100 kDa whose position was similar to our 
result, was also stained by western blot analysis shown in 
their figure [62]. This indicated the possibility that the 
protein (100 kDa or heavier) could be somehow related to ZP3 
glycoprotein, especially since both of them (65 kDa and 100 
kDa) demonstrated immunogenicity to ZP3 antibodies.
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In addition, it had been shown that PA-1 tumor cell 
produced another recombinant glycoprotein (fibronectin) with 
heavier molecular mass than its native one [111]. It could 
be explained by the activation of the glycosylation system 
in the tumor cell itself. Therefore, it is still not clear 
whether the 100 kDa (or heavier) glycoprotein produced is 
really hZP3-related glycoprotein or a by-product due to 
overglycosylation of the hZP3 protein in tumor cells.
By using 3H-galactose, a metabolic labelling study 
was performed as described in Methods to identify the newly 
biosynthesized and secreted glycoproteins. In the ^-ga­
lactose labelling metabolic study, the 100 kDa (or heavier) 
glycoprotein was distinct and obviously a product of the 
transfected cells (Fig 16) which implied that it is either a 
product of the introduced hZP3/pREP4 DNA construct or 
induced by the products of the introduced DNA construct in 
PA-1 cells. In addition, the total amount of glycoproteins 
produced in the transfected cells was about 3.29 times more 
than that in the non-transfected cells, and there may be a 
large amount of the biosynthesized recombinant glycoproteins 
(up to 10 millions cpm) which have not been secreted and are 
left inside the transfected cells (Table 2).
According to the results of SDS-PAGE with silver stain 
(Fig 14), 3H-galactose labelling metabolic study (Fig 16), 
and especially Western blot analysis (Fig 15), the molecular 
mass of the recombinant hZP3 glycoproteins produced by the
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
transfected cells of human ovarian cell line (PA-1) was 
about 65 kDa. In addition, the non-glycosylated polypeptide 
backbone of hZP3 is 47 kDa as mentioned previously and a 
complex type N-linked or O-linked oligosaccharide is about 
3-4 kDa. In this case, it implies that there ought to be 
four to six carbohydrate side chains (account for 18 kDa) in 
one molecule of hZP3 glycoprotein. And at least one or some 
of them must be O-linked carbohydrate side chains because it 
is believed that it is the O-linked carbohydrate side chains 
that are responsible for the biological activity of the hZP3 
glycoprotein as receptor ligand of sperm cell [39,48] .
Carbohydrate chains are believed to be able to 
stabilize the protein itself and a hZP3 molecule contained 
at least 18 kDa of carbohydrate side chains according to our 
results. This may be one of the reasons why the half-life of 
the zona pellucida proteins is so long (>100 hr and may be 
up to 10 days) [39,40]. On the other hand, zona pellucida 
proteins may polymerize and are organized as a filament 
structure [5,7,44]. This implies that there may be distinct 
molecular structure of the zona pellucida proteins in their 
polypeptide backbone that will enhance their protein-protein 
polymerization, or some specific metabolic pathway or 
intracellular signal transduction mechanism may exist to 
assemble this special organelle in the female germ cell 
during development.
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C. Biological functions of hZP3
As mentioned before, hZP3 is expected to be the first 
receptor to bind and recognize sperm, and the hemizona assay 
(HZA) has been proven to be the best method to test the 
biological function of binding and recognition between sperm 
and egg [40,91]. Indeed, the biological activity of the 
recombinant hZP3 demonstrated significant results in the 
hemizona assay (Fig 17), and it was also demonstrated to be 
effective in the acrosome reaction assay (AR) in preliminary 
experiments. Ham's F-10 and the culture medium from non­
transfected cells were used as negative controls to do a 
reasonable adjustment of the results in the bio-assays (HZA 
and AR). In addition, the paired t-test was applied to 
statistically analyze the results between test and control 
groups in the HZA. These results strongly suggest that hZP3 
is really functioning as a receptor to bind sperm as well as 
inducer of the acrosome reaction.
To further investigate the molecular mechanisms of 
human sperm-zona pellucida interaction, future research will 
involve the following: (1) studies of signal transduction
events after the recognition and binding of the receptors of 
zona pellucida and sperm cell at the cellular level (for 
example, Ca2+ influx), (2) dose-dependent and time-course
studies of the recombinant hZP3 in the Hemizona assay (HZA) 
and Acrosome reaction assay (AR), and (3) further 
purification (i.e. immunoaffinity) of the recombinant hZP3
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and amino acid sequencing.
D. Conclusion
In conclusion, this study has fulfilled our specific 
aims based on the following experiment results:
(1) The full-length cDNA of hZP3 has been successfully 
produced, identified and subcloned into expression vectors 
as proposed.
(2) A stable-transfected cell line has been produced 
by introduction of the hZP3/expression vector DNA construct 
into a human ovarian cell line, PA-1, and identified based 
on the following criteria: PCR, RT-PCR, and ELISA.
(3) The isolation of a secreted recombinant 
glycoprotein has been accomplished by WGA-Lectin 
chromatography and anti-WGA immunoaffinity chromatography.
(4) The secreted recombinant hZP3 has been identified 
by the following criteria: immunogenicity (ELISA and Western 
blot analysis) , molecular mass (in vitro translation, and 
SDS-PAGE with silver stain) , and biological characterization 
(HZA and AR) . In addition, in the biological 
characterization, the recombinant glycoprotein demonstrated 
the dual functions of hZP3 (i . e. sperm-binding and induction 
of acrosome reaction) .
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APPENDIX I
Sequence of the cDNA of hZP3 (J. Dean) and the locations and 
orientations of the primers and probe designed for this 
study (attach behind)
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APPENDIX II
Estimated cell number in various culture dishes
Internal Area(cm2) Cell Number(x million)












4 .00 50.26 14
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APPENDIX III
Autosequencing of the RT-PCR product (cDNA of hZP3) by 
taking advantage of the T3 promoter inherent in the hZP3/PSK 
DNA construct
This sequence read was reversed and complementary to 
that of hZP3 cDNA published by J. Dean (see Appendix I) .
The position of the first base (base 1278) of hZP3 
cDNA identified was marked in the figure attached behind.
Ill
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APPENDIX IV
Autosequencing of the RT-PCR product (cDNA of hZP3) by 
taking advantage of the T7 promoter inherent in the hZP3/PSK 
DNA construct
The position of the first base (base 1) of the hZP3 
cDNA identified was marked in the figure attached behind.
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APPENDIX V
Sperm motility examination
Conclusion: There was no significant toxic effect of the 
recombinant hZP3 (rZP3) found on the sperm motility.
% Motility
Ham’s 79 ± 2
rZP3 (1:4) 72 ± 3.5
NTM 74 ± .5
rZP3 (1:4) 76 ±1
Ham's 71 ± 2
rZP3 (1:8) 64 ± 4
NTM 77 ± 2
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APPENDIX VI
Computer print-out of the statistic analysis of the 
hemizona assay results by single (paired) t-test.
The larger the |t| score and the smaller the p score (two- 
tailed test) are, the more significant the results 
demonstrate.
6 cases with 2 variables
1 1 2
11 c T1“11 54.000 29.000
| 2 26.000 0.000
I 3 41.000 42.000
|4 30.000 15.000
1 5 45.000 22.000
|6 20.000 23.000
C: Control group (the non-transfected medium)
T: Test group (1:4 dilution of rZP3 solution)
Number of sperm cells bound to the identical 
pairs of hemizonae (6 pairs)
I__L
I
| css/3: Single t-Tests
i
| basic N. of Cases - 6
| stats (MD casewlse deleted)
. . .  , , | (
1 1 




-2.6446534129700 j .04571945965290 |
i i 6 1i
i| css/3: 'Single t-Tests
| basic N. of Cases - 6




j T-Ci -14.166666666667 | 13.1212301093170
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APPENDIX VII
Other informations
1) . 1 pmol of 1.3 kb of double-strands DNA = 0.48 fig
2). 50 pmol of 21 bp primer = 0.5 in a 50 ^1 final 
reaction volume
3) . 1 A260 unit of 10 bases linker = 50 fig
4) . 1 fiCi = 2.2 x 106 cpm
5) . [RNA] = a260 x 40.0 ^g/ml
6). [DNA] = A260 x 50.0 fig/ml
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APPENDIX VIII
Comparison of the length of hZP3 gene and its cDNA.
The human ZP3 gene is composed of eight exons and 
corresponds to 18.3 kilobase-pairs of DNA, while the cDNA of 




Exon 1 3 4 5 6 7
Human ZP3 Gene
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